NEK6
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | S161 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00141 | S377 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SGK1 SGK | LINWDDLINKKItPPFNPNVsGPNDLRHFDPEFTEEPVPNs |
| O00141 | S422 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SGK1 SGK | PDsVLVTAsVKEAAEAFLGFsYAPPTDSFL___________ |
| O00170 | S53 | Sugiyama | AIP XAP2 | KATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKFKLPVW |
| O00273 | T300 | Sugiyama | DFFA DFF1 DFF45 H13 | KKTETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDL |
| O00443 | S108 | Sugiyama | PIK3C2A | LDIDVEKLTQAELEKLLLDDsFETKKTPVLPVTPILSPSFS |
| O00443 | S59 | Sugiyama | PIK3C2A | LAKLQKDRQVTDNQRGFELsssTRKKAQVyNKQDyDLMVFP |
| O00443 | S60 | Sugiyama | PIK3C2A | AKLQKDRQVTDNQRGFELsssTRKKAQVyNKQDyDLMVFPE |
| O14737 | S51 | Sugiyama | PDCD5 TFAR19 | EAKHREAEMRNsILAQVLDQsARARLsNLALVKPEKTKAVE |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O15067 | S225 | Sugiyama | PFAS KIAA0361 | KRFQELQRNPstVEAFDLAQsNsEHSRHWFFKGQLHVDGQK |
| O15067 | S227 | Sugiyama | PFAS KIAA0361 | FQELQRNPstVEAFDLAQsNsEHSRHWFFKGQLHVDGQKLV |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15355 | S363 | Sugiyama | PPM1G PPM1C | VANAGDsRCVVsEAGKALDMsyDHKPEDEVELARIKNAGGK |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15397 | S29 | Sugiyama | IPO8 RANBP8 | ALKGTIDPKLRIAAENELNQsYKIINFAPSLLRIIVSDHVE |
| O43175 | S14 | Sugiyama | PHGDH PGDH3 | _______MAFANLRKVLIsDsLDPCCRKILQDGGLQVVEKQ |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43615 | S94 | Sugiyama | TIMM44 MIMT44 TIM44 | NKEMKESIKKFRDEARRLEEsDVLQEARRKyKtIESETVRT |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43707 | T612 | Sugiyama | ACTN4 | KEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPK |
| O43707 | T613 | Sugiyama | ACTN4 | EAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPKR |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60231 | S56 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | RCTSAEEFVQRLRDtDTLDLsGPARDFALRLWNKVPRKAVV |
| O60271 | S815 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | IASVPGARETDYPAGEDLsEsGQVDKASLCGSMTSNSSAET |
| O60271 | T191 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | MEHLERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLPA |
| O60271 | T418 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | DEGADLLGMGREVENLILENtQLLEtKNALNIVKNDLIAKV |
| O60271 | T423 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | LLGMGREVENLILENtQLLEtKNALNIVKNDLIAKVDELTC |
| O60343 | S304 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASQPALTSSRVCFPERILEDsGFDEQQEFRsRCssVTGVQR |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60566 | T608 | Sugiyama | BUB1B BUBR1 MAD3L SSK1 | SEDAIITGFRNVtICPNPEDtCDFARAARFVStPFHEIMSL |
| O60664 | S254 | Sugiyama | PLIN3 M6PRBP1 TIP47 | SyFVRLGsLSERLRQHAyEHsLGKLRATKQRAQEALLQLSQ |
| O60701 | S381 | Sugiyama | UGDH | GAHLHIYDPKVPREQIVVDLsHPGVSEDDQVsRLVTISKDP |
| O60749 | S354 | Sugiyama | SNX2 TRG9 | RKELSANTAAFAKSAAMLGNsEDHTALSRALsQLAEVEEKI |
| O60763 | S880 | Sugiyama | USO1 VDP | LKNEIKALSEERTAIKEQLDssNsTIAILQTEKDKLELEIT |
| O60763 | S883 | Sugiyama | USO1 VDP | EIKALSEERTAIKEQLDssNsTIAILQTEKDKLELEITDSK |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O75116 | S930 | Sugiyama | ROCK2 KIAA0619 | SLAAQLEITLTKADSEQLARsIAEEQysDLEKEKIMKELEI |
| O75116 | T567 | Sugiyama | ROCK2 KIAA0619 | NQNSQISTEKVNQLQRQLDEtNALLRtESDTAARLRKTQAE |
| O75116 | T573 | Sugiyama | ROCK2 KIAA0619 | STEKVNQLQRQLDEtNALLRtESDTAARLRKTQAESSKQIQ |
| O75179 | S1159 | Sugiyama | ANKRD17 GTAR KIAA0697 | GADIEAQSERTKDTPLSLACsGGRQEVVELLLARGANKEHR |
| O75179 | S156 | Sugiyama | ANKRD17 GTAR KIAA0697 | ILDQDDLENPMLETASKLLLsGtADGADLRTVDPETQARLE |
| O75179 | T158 | Sugiyama | ANKRD17 GTAR KIAA0697 | DQDDLENPMLETASKLLLsGtADGADLRTVDPETQARLEAL |
| O75347 | S60 | Sugiyama | TBCA | MRAEDGENyDIKKQAEILQEsRMMIPDCQRRLEAAyLDLQR |
| O75436 | T102 | Sugiyama | VPS26A VPS26 | KSNTHEFVNLVKELALPGELtQSRSYDFEFMQVEKPYESYI |
| O75534 | S74 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | SQYNGNLQDLKVGDDVEFEVsSDRRTGKPIAVKLVKIKQEI |
| O75534 | S766 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | AAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDNsMGFG |
| O75663 | S94 | Sugiyama | TIPRL | RCVNNyQGMLKVACAEEWQEsRtEGEHSKEVIKPyDWTyTT |
| O75663 | T96 | Sugiyama | TIPRL | VNNyQGMLKVACAEEWQEsRtEGEHSKEVIKPyDWTyTTDY |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| O76094 | S524 | Sugiyama | SRP72 | KHLPSSDSMSLKVDVEALENsAGAtyIRKKGGKVTGDsQPK |
| O95235 | S240 | EPSD|PSP | KIF20A MKLP2 RAB6KIFL | EEMKKLSLLNGGLQEEELstsLKRsVYIESRIGtstsFDsG |
| O95235 | S244 | SIGNOR|EPSD|PSP | KIF20A MKLP2 RAB6KIFL | KLSLLNGGLQEEELstsLKRsVYIESRIGtstsFDsGIAGL |
| O95235 | S683 | EPSD|PSP | KIF20A MKLP2 RAB6KIFL | VAHQQsGsELALRRsQRLAAsAstQQLQEVKAKLQQCKAEL |
| O95235 | S754 | EPSD|PSP | KIF20A MKLP2 RAB6KIFL | LEEGQKNIRLLRTELQKLGEsLQsAERACCHSTGAGKLRQA |
| O95235 | S883 | EPSD|PSP | KIF20A MKLP2 RAB6KIFL | StDCsPyARILRSRRsPLLKsGPFGKKY_____________ |
| O95292 | S160 | Sugiyama | VAPB UNQ484/PRO983 | IIstTAsKtEtPIVSKsLsssLDDtEVKKVMEECKRLQGEV |
| O95479 | S106 | Sugiyama | H6PD GDH | CPKDMAPSHCAEHKDQFLQLsQYRQLKTAEDYQALNKDIEA |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95716 | T78 | Sugiyama | RAB3D GOV RAB16 | DFKVKTVYRHDKRIKLQIWDtAGQERYRtITTAYYRGAMGF |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| O95831 | T188 | Sugiyama | AIFM1 AIF PDCD8 | LPYMRPPLSKELWFSDDPNVtKtLRFKQWNGKERSIYFQPP |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P02786 | T138 | Sugiyama | TFRC | AARRLyWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAG |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04150 | S125 | Sugiyama | NR3C1 GRL | PQQGQISLSSGETDLKLLEEsIANLNRstsVPENPKSSAST |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05362 | T448 | Sugiyama | ICAM1 | ELKCLKDGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTR |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05783 | S323 | Sugiyama | KRT18 CYK18 PIG46 | VQsLEIDLDsMRNLKAsLENsLREVEARYALQMEQLNGILL |
| P05783 | S399 | Sugiyama | KRT18 CYK18 PIG46 | TYRRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVV |
| P05783 | S401 | Sugiyama | KRT18 CYK18 PIG46 | RRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsE |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P05787 | T413 | Sugiyama | KRT8 CYK8 | KLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGLtsP |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S310 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VsIEDPFDQDDWGAWQKFtAsAGIQVVGDDLTVtNPKRIAK |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T323 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AWQKFtAsAGIQVVGDDLTVtNPKRIAKAVNEKsCNCLLLK |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07355 | S161 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07814 | S1511 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PGAKCVCGKNPAKyytLFGRsy___________________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S882 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | AQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S406 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKKCLELFtE |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07942 | S448 | Sugiyama | LAMB1 | CKLNVEGEHCDVCKEGFyDLssEDPFGCKSCACNPLGTIPG |
| P08134 | T60 | Sugiyama | RHOC ARH9 ARHC | ENYIADIEVDGKQVELALWDtAGQEDYDRLRPLSYPDTDVI |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S402 | Sugiyama | SLC3A2 MDU1 | SSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQY |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | S408 | Sugiyama | SLC3A2 MDU1 | ILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNATGN |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08195 | Y404 | Sugiyama | SLC3A2 MDU1 | DLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLN |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S398 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKKCLELFsE |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09417 | S163 | Sugiyama | QDPR DHPR SDR33C1 | GTPGMIGYGMAKGAVHQLCQsLAGKNSGMPPGAAAIAVLPV |
| P09622 | S502 | Sugiyama | DLD GCSL LAD PHE3 | RVCHAHPTLSEAFREANLAAsFGKSINF_____________ |
| P09960 | S486 | Sugiyama | LTA4H LTA4 | TNACIALSQRWITAKEDDLNsFNAtDLKDLsSHQLNEFLAQ |
| P09960 | S496 | Sugiyama | LTA4H LTA4 | WITAKEDDLNsFNAtDLKDLsSHQLNEFLAQtLQRAPLPLG |
| P09960 | S581 | Sugiyama | LTA4H LTA4 | EQGRMKFTRPLFKDLAAFDKsHDQAVRTYQEHKASMHPVTA |
| P09960 | T507 | Sugiyama | LTA4H LTA4 | FNAtDLKDLsSHQLNEFLAQtLQRAPLPLGHIKRMQEVYNF |
| P09972 | S356 | Sugiyama | ALDOC ALDC | GLAAQGKYEGSGEDGGAAAQsLyIANHAY____________ |
| P09972 | S36 | Sugiyama | ALDOC ALDC | LsDIALRIVAPGKGILAADEsVGsMAKRLsQIGVENtEENR |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0DMV8 | T66 | SIGNOR|EPSD|PSP | HSPA1A HSP72 HSPA1 HSX70 | DTERLIGDAAKNQVALNPQNtVFDAKRLIGRKFGDPVVQsD |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10599 | T100 | Sugiyama | TXN TRDX TRX TRX1 | FKKGQKVGEFSGANKEKLEAtINELV_______________ |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | S67 | Sugiyama | HSPD1 HSP60 | LADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLK |
| P10809 | T428 | Sugiyama | HSPD1 HSP60 | GtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGCALLRCI |
| P10809 | T61 | Sugiyama | HSPD1 HSP60 | LQGVDLLADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVA |
| P11047 | T943 | Sugiyama | LAMC1 LAMB2 | FYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITGQ |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11586 | S872 | Sugiyama | MTHFD1 MTHFC MTHFD | YTKQGFGNLPICMAKtHLsLsHNPEQKGVPTGFILPIRDIR |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11717 | S1378 | Sugiyama | IGF2R MPRI | QYACPPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTG |
| P11717 | S1382 | Sugiyama | IGF2R MPRI | PPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTGDPEH |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12270 | S1185 | Sugiyama | TPR | KLSDKVVASVKEGVQGPLNVsLsEEGKSQEQILEILRFIRR |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | S337 | Sugiyama | CKB CKBB | LQKRGtGGVDtAAVGGVFDVsNADRLGFSEVELVQMVVDGV |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S135 | Sugiyama | PDIA4 ERP70 ERP72 | IPVAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsR |
| P13667 | S154 | Sugiyama | PDIA4 ERP70 ERP72 | VsGyPtIKILKKGQAVDyEGsRtQEEIVAKVREVSQPDWTP |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13667 | T156 | Sugiyama | PDIA4 ERP70 ERP72 | GyPtIKILKKGQAVDyEGsRtQEEIVAKVREVSQPDWTPPP |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P13798 | S303 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YYVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLI |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S447 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | PKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRK |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | S650 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KIEKAVVSQRLTESPCALVAsQyGWsGNMERIMKAQAYQtG |
| P14625 | S655 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VVSQRLTESPCALVAsQyGWsGNMERIMKAQAYQtGKDIst |
| P14625 | Y652 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | EKAVVSQRLTESPCALVAsQyGWsGNMERIMKAQAYQtGKD |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15153 | S158 | Sugiyama | RAC2 | TYPQGLALAKEIDSVKyLECsALtQRGLKtVFDEAIRAVLC |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15374 | S126 | Sugiyama | UCHL3 | NNKDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRV |
| P16455 | S22 | Sugiyama | MGMT | DKDCEMKRTTLDsPLGKLELsGCEQGLHEIKLLGKGTSAAD |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17174 | T110 | Sugiyama | GOT1 | GDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNGTNNK |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18074 | T425 | PSP | ERCC2 XPD XPDC | TLVSTYAKGFTIIIEPFDDRtPTIANPILHFSCMDASLAIK |
| P18206 | S579 | Sugiyama | VCL | AARGEGEsPQARALAsQLQDsLKDLKARMQEAMTQEVsDVF |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S591 | Sugiyama | NCL | SKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKG |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P20073 | S216 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | KAMKGFGtDEQAIVDVVANRsNDQRQKIKAAFKTSYGKDLI |
| P20336 | T78 | Sugiyama | RAB3A | DFKVKTIYRNDKRIKLQIWDtAGQERYRtITTAYYRGAMGF |
| P20337 | T78 | Sugiyama | RAB3B | DFKVKTVYRHEKRVKLQIWDtAGQERYRtITTAYYRGAMGF |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P21333 | S1029 | Sugiyama | FLNA FLN FLN1 | VGPSGAAVPCKVEPGLGADNsVVRFLPREEGPYEVEVTYDG |
| P22061 | S133 | Sugiyama | PCMT1 | KELVDDsVNNVRKDDPTLLssGRVQLVVGDGRMGYAEEAPY |
| P22102 | S105 | Sugiyama | GART PGFT PRGS | NLRsAGVQCFGPTAEAAQLEssKRFAKEFMDRHGIPTAQWK |
| P22102 | S106 | Sugiyama | GART PGFT PRGS | LRsAGVQCFGPTAEAAQLEssKRFAKEFMDRHGIPTAQWKA |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S324 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNYNQQPSNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGs |
| P22692 | S255 | Sugiyama | IGFBP4 IBP4 | VKLPGGLEPKGELDCHQLADsFRE_________________ |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23443 | S403 | GPS6|SIGNOR|EPSD|PSP | RPS6KB1 STK14A | DSKFtRQtPVDsPDDstLsEsANQVFLGFtYVAPSVLESVK |
| P23443 | S53 | GPS6|SIGNOR|EPSD|PSP | RPS6KB1 STK14A | DQPEDAGSEDELEEGGQLNEsMDHGGVGPYELGMEHCEKFE |
| P23443 | T412 | GPS6|EPSD|PSP | RPS6KB1 STK14A | VDsPDDstLsEsANQVFLGFtYVAPSVLESVKEKFsFEPKI |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23526 | T185 | Sugiyama | AHCY SAHH | yKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGIKR |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S156 | Sugiyama | YWHAQ | DDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLGLALNFSV |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | T229 | Sugiyama | YWHAQ | DsyKDstLIMQLLRDNLTLWtsDsAGEECDAAEGAEN____ |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27695 | S135 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | SHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEG |
| P27695 | T97 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KKKGLDWVKEEAPDILCLQEtKCSENKLPAELQELPGLSHQ |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28482 | T351 | Sugiyama | MAPK1 ERK2 PRKM1 PRKM2 | FDMELDDLPKEKLKELIFEEtARFQPGYRS___________ |
| P28838 | S194 | Sugiyama | LAP3 LAPEP PEPS | SAKLyGsGDQEAWQKGVLFAsGQNLARQLMETPANEMTPtR |
| P29144 | S1039 | Sugiyama | TPP2 | EEFTEALRDLKIQWMTKLDSsDIyNELKEtyPNyLPLyVAR |
| P29144 | S93 | Sugiyama | TPP2 | SGDVNTATEVEPKDGEIVGLsGRVLKIPASWTNPSGKYHIG |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S439 | Sugiyama | TKT | VSIGEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVE |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30040 | T43 | Sugiyama | ERP29 C12orf8 ERP28 | LLSAPHGGSGLHTKGALPLDtVtFyKVIPKSKFVLVKFDtQ |
| P30040 | T45 | Sugiyama | ERP29 C12orf8 ERP28 | SAPHGGSGLHTKGALPLDtVtFyKVIPKSKFVLVKFDtQyP |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30740 | S281 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | PENLDFIEVNVSLPRFKLEEsYTLNSDLARLGVQDLFNssK |
| P30876 | S882 | Sugiyama | POLR2B | GDDVIIGKTVtLPENEDELEstNRRYTKRDCSTFLRTSETG |
| P31150 | S213 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | RTDDyLDQPCLETVNRIKLYsEsLARYGKsPYLyPLyGLGE |
| P31327 | S205 | Sugiyama | CPS1 | FEGQPVDFVDPNKQNLIAEVstKDVKVYGKGNPTKVVAVDC |
| P31327 | S808 | Sugiyama | CPS1 | IGSSMKsVGEVMAIGRTFEEsFQKALRMCHPsIEGFTPRLP |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P31327 | T903 | Sugiyama | CPS1 | DILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKCLGL |
| P31327 | T924 | Sugiyama | CPS1 | LKRAKEIGFSDKQISKCLGLtEAQTRELRLKKNIHPWVKQI |
| P31939 | S370 | Sugiyama | ATIC PURH OK/SW-cl.86 | ALTILSKKKNGNyCVLQMDQsYKPDENEVRTLFGLHLsQKR |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31946 | S147 | Sugiyama | YWHAB | YFRyLsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHP |
| P31946 | S158 | Sugiyama | YWHAB | DNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | T228 | Sugiyama | YWHAB | LNEEsyKDstLIMQLLRDNLtLWtSENQGDEGDAGEGEN__ |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32929 | S63 | Sugiyama | CTH | LSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGAKY |
| P33176 | S443 | Sugiyama | KIF5B KNS KNS1 | EEIAKLYKQLDDKDEEINQQsQLVEKLKTQMLDQEELLAST |
| P34896 | S17 | Sugiyama | SHMT1 | ____MTMPVNGAHKDADLWSsHDKMLAQPLKDSDVEVyNII |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P34932 | T365 | Sugiyama | HSPA4 APG2 HSPH2 | TRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILsP |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35237 | S306 | Sugiyama | SERPINB6 PI6 PTI | LRNLGMTDAFELGKADFSGMsQTDLSLSKVVHKSFVEVNEE |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | T1146 | Sugiyama | MYH9 | sRNKAEKQKRDLGEELEALKtELEDtLDstAAQQELRSKRE |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1155 | Sugiyama | MYH9 | RDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKKT |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35613 | S368 | SIGNOR | BSG UNQ6505/PRO21383 | RRKPEDVLDDDDAGsAPLKssGQHQNDKGKNVRQRNSS___ |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36871 | S134 | Sugiyama | PGM1 | LtAsHNPGGPNGDFGIKFNIsNGGPAPEAITDKIFQISKTI |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | S200 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | NyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNVLRVI |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S550 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYAE |
| P38646 | S554 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | AKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYAEEDRR |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40763 | S727 | GPS6|SIGNOR|EPSD|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P40763 | Y705 | SIGNOR|PSP | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P40925 | S153 | Sugiyama | MDH1 MDHA | ANtNCLtAsKSAPSIPKENFsCLtRLDHNRAKAQIALKLGV |
| P41252 | T1068 | Sugiyama | IARS1 IARS | PsDKVLIQEKTQLKGSELEItLTRGSSLPGPACAYVNLNIC |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S161 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | DFERtLKGHtDsVQDIsFDHsGKLLASCSADMTIKLWDFQG |
| P43243 | T239 | Sugiyama | MATR3 KIAA0723 | yEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGP |
| P43490 | S180 | Sugiyama | NAMPT PBEF PBEF1 | TVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSS |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46937 | S388 | Sugiyama | YAP1 YAP65 | PGMsQELRTMttNssDPFLNsGtyHsRDEstDsGLsMssys |
| P46937 | S405 | Sugiyama | YAP1 YAP65 | FLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDT |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48426 | S115 | Sugiyama | PIP4K2A PI5P4KA PIP5K2 PIP5K2A | PMVFRNLRERFGIDDQDFQNsLTRSAPLPNDSQARSGARFH |
| P48444 | S253 | Sugiyama | ARCN1 COPD | KEVDNFVDKLKsEGEtIMSssMGKRTSEATKMHAPPINMES |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49327 | S2039 | Sugiyama | FASN FAS | FSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLPGLAVQ |
| P49327 | S2465 | Sugiyama | FASN FAS | LLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHRTLL |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | S212 | Sugiyama | CCT3 CCTG TRIC5 | EIDIKKYARVEKIPGGIIEDsCVLRGVMINKDVTHPRMRRY |
| P49368 | S244 | Sugiyama | CCT3 CCTG TRIC5 | VTHPRMRRYIKNPRIVLLDssLEyKKGEsQtDIEITREEDF |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49588 | T164 | Sugiyama | AARS1 AARS | AGLEADLECKQIWQNLGLDDtKILPGNMKDNFWEMGDtGPC |
| P49588 | T181 | Sugiyama | AARS1 AARS | LDDtKILPGNMKDNFWEMGDtGPCGPCsEIHyDRIGGRDAA |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49589 | S307 | Sugiyama | CARS1 CARS | VPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKASK |
| P49792 | S1613 | Sugiyama | RANBP2 NUP358 | KAPKSGFEGMFTKKEGQWDCsVCLVRNEASATKCIACQNPG |
| P50395 | S213 | Sugiyama | GDI2 RABGDIB | RtDDyLDQPCyEtINRIKLYsEsLARYGKsPYLyPLyGLGE |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50395 | T413 | Sugiyama | GDI2 RABGDIB | GtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFEE |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50542 | S167 | Sugiyama | PEX5 PXR1 | EVTDPLSVSPARWAEEyLEQsEEKLWLGEPEGTATDRWYDE |
| P50570 | S357 | Sugiyama | DNM2 DYN2 | GVDFEKRIEGSGDQVDTLELsGGARINRIFHERFPFELVKM |
| P50613 | S161 | GPS6|EPSD|PSP | CDK7 CAK CAK1 CDKN7 MO15 STK1 | NNLLLDENGVLKLADFGLAKsFGsPNRAytHQVVtRWYRAP |
| P50897 | T261 | Sugiyama | PPT1 CLN1 PPT | SEWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLV |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50995 | S490 | Sugiyama | ANXA11 ANX11 | RSEYKRMYGKsLyHDISGDtsGDyRKILLKICGGND_____ |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51946 | S322 | Sugiyama | CCNH | YVsKKSKHEEEEWtDDDLVEsL___________________ |
| P52272 | S633 | Sugiyama | HNRNPM HNRPM NAGR1 | GGGGAsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKAC |
| P52272 | S637 | Sugiyama | HNRNPM HNRPM NAGR1 | AsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKACQIFV |
| P52429 | T204 | Sugiyama | DGKE DAGK5 | NLIIPPSYLTSINQMRKDKKtDyEVLASKLGKQWTPLIILA |
| P52429 | Y206 | Sugiyama | DGKE DAGK5 | IIPPSYLTSINQMRKDKKtDyEVLASKLGKQWTPLIILANS |
| P52597 | S107 | Sugiyama | HNRNPF HNRPF | KSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTKEEI |
| P52732 | S1033 | GPS6|SIGNOR|EPSD|PSP | KIF11 EG5 KNSL1 TRIP5 | QHKKSHGKDKENRGINTLERsKVEETtEHLVTKSRLPLRAQ |
| P52789 | S889 | Sugiyama | HK2 | PHFAKVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVAC |
| P52789 | S893 | Sugiyama | HK2 | KVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVACRIRE |
| P52888 | S29 | Sugiyama | THOP1 | GDMADAAsPCSVVNDLRWDLsAQQIEERTRELIEQTKRVyD |
| P52907 | S219 | Sugiyama | CAPZA1 | YEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAENEy |
| P52948 | S608 | SIGNOR | NUP98 ADAR2 | NGAFMPKKsIKKLVLKNLNNsNLFsPVNRDsENLAsPsEyP |
| P52948 | S839 | SIGNOR | NUP98 ADAR2 | AEVtLDGVWPTDKTSRCLIKsPDRLADINyEGRLEAVSRKQ |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53621 | S389 | Sugiyama | COPA | SYNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPE |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P53675 | S1016 | Sugiyama | CLTCL1 CLH22 CLTCL CLTD | MTADLPNELIELLEKIVLDNsVFSEHRNLQNLLILTAIKAD |
| P54105 | S193 | Sugiyama | CLNS1A CLCI ICLN | GLSHLTAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRD |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55036 | T264 | Sugiyama | PSMD4 MCB1 | AEAGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEE |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55072 | S765 | Sugiyama | VCP HEL-220 HEL-S-70 | RsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGAGPsQ |
| P55072 | T761 | Sugiyama | VCP HEL-220 HEL-S-70 | RFARRsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGA |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P58546 | T108 | Sugiyama | MTPN | LSKGADKTVKGPDGLTAFEAtDNQAIKALLQ__________ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60228 | S442 | Sugiyama | EIF3E EIF3S6 INT6 | IEKKLNQNSRSEAPNWAtQDsGFy_________________ |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60763 | S158 | Sugiyama | RAC3 | TYPQGLAMAREIGSVKyLECsALtQRGLKtVFDEAIRAVLC |
| P60842 | S300 | Sugiyama | EIF4A1 DDX2A EIF4A | NTRRKVDWLTEKMHARDFTVsAMHGDMDQKERDVIMREFRs |
| P60981 | S88 | Sugiyama | DSTN ACTDP DSN | FKHFVGMLPEKDCRyALyDAsFETKESRKEELMFFLWAPEL |
| P61006 | T64 | Sugiyama | RAB8A MEL RAB8 | DFKIRTIELDGKRIKLQIWDtAGQERFRtITTAYYRGAMGI |
| P61018 | T64 | Sugiyama | RAB4B RAB4 PP1596 | EFGSRVVNVGGKTVKLQIWDtAGQERFRSVTRSYYRGAAGA |
| P61026 | T65 | Sugiyama | RAB10 | DFKIKTVELQGKKIKLQIWDtAGQERFHtIttsYYRGAMGI |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61106 | T67 | Sugiyama | RAB14 | EFGTRIIEVSGQKIKLQIWDtAGQERFRAVTRSYYRGAAGA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S12 | Sugiyama | RPL26 | _________MKFNPFVtsDRsKNRKRHFNAPsHIRRKIMss |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61586 | S160 | Sugiyama | RHOA ARH12 ARHA RHO12 | KPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtRAALQ |
| P61586 | T60 | Sugiyama | RHOA ARH12 ARHA RHO12 | ENyVADIEVDGKQVELALWDtAGQEDyDRLRPLSYPDTDVI |
| P61978 | S36 | Sugiyama | HNRNPK HNRPK | NGEFGKRPAEDMEEEQAFKRsRNtDEMVELRILLQSKNAGA |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61978 | T39 | Sugiyama | HNRNPK HNRPK | FGKRPAEDMEEEQAFKRsRNtDEMVELRILLQSKNAGAVIG |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T231 | Sugiyama | YWHAG | LNEDsyKDstLIMQLLRDNLtLWtsDQQDDDGGEGNN____ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62495 | S239 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | VNVAGLVLAGSADFKTELSQsDMFDQRLQSKVLKLVDISYG |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62745 | T60 | Sugiyama | RHOB ARH6 ARHB | ENYVADIEVDGKQVELALWDtAGQEDYDRLRPLSYPDTDVI |
| P62820 | T67 | Sugiyama | RAB1A RAB1 | DFKIRTIELDGKTIKLQIWDtAGQERFRtItsSYYRGAHGI |
| P62826 | S150 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARKLIG |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62873 | S207 | Sugiyama | GNB1 | VMSLSLAPDTRLFVSGACDAsAKLWDVREGMCRQTFTGHES |
| P62879 | S207 | Sugiyama | GNB2 | VMSLSLAPDGRTFVSGACDAsIKLWDVRDSMCRQTFIGHES |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63000 | S158 | Sugiyama | RAC1 TC25 MIG5 | TYPQGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIRAVLC |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T226 | Sugiyama | YWHAZ | LsEEsyKDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_ |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63146 | S148 | Sugiyama | UBE2B RAD6B UBCH1 | QLYQENKREYEKRVsAIVEQsWNDS________________ |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P78527 | S3363 | Sugiyama | PRKDC HYRC HYRC1 | SEPACLAEIEEDKARRILELsGsssEDsEKVIAGLyQRAFQ |
| P78527 | T2645 | Sugiyama | PRKDC HYRC HYRC1 | LSARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstD |
| P78527 | T2647 | Sugiyama | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P78527 | T2649 | Sugiyama | PRKDC HYRC HYRC1 | WPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPLVD |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q00403 | S99 | Sugiyama | GTF2B TF2B TFIIB | DLsTMIGKGTGAAsFDEFGNsKYQNRRTMSSSDRAMMNAFK |
| Q00610 | S1016 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | MTADLPNELIELLEKIVLDNsVFSEHRNLQNLLILTAIKAD |
| Q00610 | S1222 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | GDRCyDEKMyDAAKLLyNNVsNFGRLAstLVHLGEyQAAVD |
| Q00610 | S886 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | IHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsRVVG |
| Q00653 | S739 | Sugiyama | NFKB2 LYT10 | GPEKDtRssFRGHtPLDLTCstKVKTLLLNAAQNTMEPPLT |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q04637 | S1134 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RPAtstLNRFsALQQAVPtEsTDNRRVVQRssLsRERGEKA |
| Q04637 | T1132 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | AARPAtstLNRFsALQQAVPtEsTDNRRVVQRssLsRERGE |
| Q04695 | S277 | Sugiyama | KRT17 | RDQYEKMAEKNRKDAEDWFFsKTEELNREVATNsELVQSGK |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04837 | S79 | Sugiyama | SSBP1 SSBP | LATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPGLRDVAy |
| Q04864 | S272 | Sugiyama | REL | AITEPVTVKMQLRRPSDQEVsEsMDFRYLPDEKDTYGNKAK |
| Q04864 | S274 | Sugiyama | REL | TEPVTVKMQLRRPSDQEVsEsMDFRYLPDEKDTYGNKAKKQ |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | T231 | Sugiyama | YWHAH YWHA1 | LNEDsyKDstLIMQLLRDNLtLWTSDQQDEEAGEGN_____ |
| Q05586 | S890 | EPSD|PSP | GRIN1 NMDAR1 | AEPDPKKKATFRAITSTLAssFKRRRssKDTSTGGGRGALQ |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06265 | S287 | Sugiyama | EXOSC9 PMSCL1 | KALENDQKVRKEGGKFGFAEsIANQRITAFKMEKAPIDtsD |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | S30 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | HPAPNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTF |
| Q06830 | S32 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | APNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVC |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q08211 | S130 | Sugiyama | DHX9 DDX9 LKP NDH2 | GGPLPPHLALKAENNsEVGAsGyGVPGPTWDRGANLKDYYS |
| Q08345 | S788 | EPSD|PSP | DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE | ATRNCLVGENFTIKIADFGMsRNLyAGDyyRVQGRAVLPIR |
| Q08378 | S1093 | Sugiyama | GOLGA3 | SQELEESREKVLELEDELQEsRGFRKKIKRLEESNKKLALE |
| Q08378 | S501 | Sugiyama | GOLGA3 | ERAMTDLQNMLEAKNAsLAssNNDLQVAEEQyQRLMAKVED |
| Q08999 | S659 | EPSD|PSP | RBL2 RB2 | sPLtPRRVtEVRADTGGLGRsItsPTtLyDRYssPPAStTR |
| Q08AD1 | S476 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NRGITRsIsNEGLtLNNsHVsKHIRKNLSFKPINGEEEAEs |
| Q08AD1 | T469 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | SVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLSFKPIN |
| Q13042 | T585 | Sugiyama | CDC16 ANAPC6 | FREFEVEKQTAEEtGLtPLEtsRKTPDSRPSLEETFEIEMN |
| Q13136 | S846 | Sugiyama | PPFIA1 LIP1 | ALGQAGVSETDNssQDALGLsKLGGQAEKNRKLQKKHELLE |
| Q13136 | T199 | Sugiyama | PPFIA1 LIP1 | RERLRVALERCSLLEEELGAtHKELMILKEQNNQKKTLTDG |
| Q13148 | S292 | Sugiyama | TARDBP TDP43 | RsGRFGGNPGGFGNQGGFGNsRGGGAGLGNNQGsNMGGGMN |
| Q13200 | S361 | SIGNOR|PSP | PSMD2 TRAP2 | EPKVPDDIyKtHLENNRFGGsGsQVDSARMNLASSFVNGFV |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | T255 | Sugiyama | G3BP1 G3BP | PADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPHVV |
| Q13283 | Y363 | Sugiyama | G3BP1 G3BP | FIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGFV |
| Q13332 | S180 | Sugiyama | PTPRS | GNPDPEITWFKDFLPVDPSAsNGRIKQLRSETFESTPIRGA |
| Q13347 | S217 | Sugiyama | EIF3I EIF3S2 TRIP1 | sRDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAAL |
| Q13439 | S993 | Sugiyama | GOLGA4 | KLLDQEAKLKKELENTALELsQKEKQFNAKMLEMAQANSAG |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13561 | S391 | Sugiyama | DCTN2 DCTN50 | LTQVQTTMRENLATVEGNFAsIDERMKKLGK__________ |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13617 | S230 | Sugiyama | CUL2 | PFLTETGEYYKQEASNLLQEsNCSQYMEKVLGRLKDEEIRC |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14141 | S408 | Sugiyama | SEPTIN6 KIAA0128 SEP2 SEPT6 | sLDDEVNAFKQRKTAAELLQsQGsQAGGsQtLKRDKEKKNN |
| Q14151 | S194 | Sugiyama | SAFB2 KIAA0138 | PAQPPEHAVDGEGFKNtLEtssLNFKVtPDIEEsLLEPENE |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14192 | S13 | Sugiyama | FHL2 DRAL SLIM3 | ________MTERFDCHHCNEsLFGKKYILREESPYCVVCFE |
| Q14192 | S257 | Sugiyama | FHL2 DRAL SLIM3 | IsFEERQWHNDCFNCKKCsLsLVGRGFLTERDDILCPDCGK |
| Q14203 | T714 | Sugiyama | DCTN1 | AHERSLDFLIELLHKDQLDEtVNVEPLTKAIKYYQHLYSIH |
| Q14247 | S432 | Sugiyama | CTTN EMS1 | EERLPssPVyEDAAsFKAELsyRGPVsGtEPEPVysMEAAD |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14566 | T195 | Sugiyama | MCM6 | TQPNICRNPVCANRRRFLLDtNKSRFVDFQKVRIQETQAEL |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14694 | S253 | Sugiyama | USP10 KIAA0190 | GSDTRTAGQPEGGPGADFGQsCFPAEAGRDtLsRTAGAQPC |
| Q14697 | S169 | Sugiyama | GANAB G2AN KIAA0088 | IILTARPFRLDLLEDRSLLLsVNARGLLEFEHQRAPRVsQG |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14980 | S1149 | Sugiyama | NUMA1 NMP22 NUMA | VSKLEQQCQKQQEQADsLERsLEAERASRAERDsALEtLQG |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15043 | S56 | Sugiyama | SLC39A14 KIAA0062 ZIP14 | PAISAASFLQDLIHRYGEGDsLTLQQLKALLNHLDVGVGRG |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | S375 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GYPAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGst |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15149 | S4590 | Sugiyama | PLEC PLEC1 | KYLTCPKTKLKISYKDALDRsMVEEGTGLRLLEAAAQstKG |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15185 | S64 | Sugiyama | PTGES3 P23 TEBP | sDNFKHLNEIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQ |
| Q15286 | T64 | Sugiyama | RAB35 RAB1C RAY | DFKIRtVEINGEKVKLQIWDtAGQERFRtITSTYYRGTHGV |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15643 | S1376 | Sugiyama | TRIP11 CEV14 | LQEKDATIRTLQENNHRLSDsIAATSELERKEHEQTDSEIK |
| Q15751 | S1541 | Sugiyama | HERC1 | sDEEGYALsGRRNVDLDLAAsHRKRGPMHSQLESLSDsWAR |
| Q15751 | S440 | Sugiyama | HERC1 | TDGSVRACGKGSYGRLGLGDsNNQSTLKKLTFEPHRSIKKV |
| Q15771 | T65 | Sugiyama | RAB30 | DFMIKTVEINGEKVKLQIWDtAGQERFRSITQSYYRSANAL |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q16762 | S35 | Sugiyama | TST | WLAESIRTGKLGPGLRVLDAsWysPGTREARKEYLERHVPG |
| Q27J81 | S1192 | Sugiyama | INF2 C14orf151 C14orf173 | EDEDEEDtAPEsALDtsLDKsFsEDAVtDssGsGtLPRARG |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q49A26 | S540 | Sugiyama | GLYR1 HIBDL NDF NP60 NPAC | PTPMAAAANEVYKRAKALDQsDNDMSAVyRAYIH_______ |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5JRX3 | S997 | Sugiyama | PITRM1 KIAA1104 MP1 PREP | FLYGLSDEMKQAHREQLFAVsHDKLLAVSDRYLGTGKSTHG |
| Q5SW79 | S551 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | DyNRPVINEKHKDLIKDWALssAAAVMEERKPLTTSGFHHs |
| Q5T4S7 | S2743 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | NtPMGDKDDDDDDDADEKMQsSGIPNGGHIRQESQEQSEVD |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DD87 | S104 | Sugiyama | ZNF787 | HQRTHtGERPNACADCGKTFsQSSHLVQHRRIHtGEKPYAC |
| Q6FI81 | S307 | Sugiyama | CIAPIN1 CUA001 PRO0915 | sCPyLGMPAFKPGEKVLLsDsNLHDA_______________ |
| Q6IQ22 | T98 | Sugiyama | RAB12 | DFKIKTVELRGKKIRLQIWDtAGQERFNsITSAYYRSAKGI |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | S727 | Sugiyama | SND1 TDRD11 | LEKLMENMRNDIAsHPPVEGsyAPRRGEFCIAKFVDGEWYR |
| Q7KZF4 | S909 | Sugiyama | SND1 TDRD11 | RLNLWRyGDFRADDADEFGysR___________________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z6J9 | S189 | Sugiyama | TSEN54 SEN54 | RRFQPSSVLsPYERQLNLDAsVQHLEDGDGKRKRSSSSPRS |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86W92 | S638 | Sugiyama | PPFIBP1 KIAA1230 | GTRATAGPRLGWsRDLGQsNsDLDMPFAKWTKEQVCNWLME |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q86YS6 | T74 | Sugiyama | RAB43 RAB41 | DFTMKTLEIQGKRVKLQIWDtAGQERFRTITQSYYRSANGA |
| Q8IUD2 | S824 | Sugiyama | ERC1 ELKS KIAA1081 RAB6IP2 | KKKsAQMLEEARRREDNLNDsSQQLQDSLRKKDDRIEELEE |
| Q8IV08 | S479 | Sugiyama | PLD3 | QLEAIFLRDWDSPYSHDLDTsADSVGNACRLL_________ |
| Q8IWW6 | S223 | Sugiyama | ARHGAP12 | GEGSERIHQDSEsGDELSSSsTEQIRAttPPNQGRPDsPVy |
| Q8IWZ3 | S1131 | Sugiyama | ANKHD1 KIAA1085 MASK VBARP PP2500 | GGDIEAQSERTKDTPLSLACsGGRQEVVDLLLARGANKEHR |
| Q8IX12 | S1075 | Sugiyama | CCAR1 CARP1 DIS | LQLLEEKTDEDEKTILNLENsNKsLsGELREVKKDLsQLQE |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IXW5 | S433 | Sugiyama | RPAP2 C1orf82 | IsDPDSHFPAWREsQNsLDEsLPFRGSGTAIKPLPSYENLK |
| Q8N1F7 | S72 | Sugiyama | NUP93 KIAA0095 | sQETADVKASVLLGsRGLDIsHIsQRLEsLsAAtTFEPLEP |
| Q8N4X5 | S711 | Sugiyama | AFAP1L2 KIAA1914 XB130 | KEKRELKETLLKCTDKEVLAsLEQKLKEIDEECRGEESRRV |
| Q8N6H7 | S368 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | VGTFASGPPKYKDNPFsLGEsFGsRWDTDAAWGMDRVEEKE |
| Q8N806 | S263 | Sugiyama | UBR7 C14orf130 | QGKDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESK |
| Q8NBJ7 | S264 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | AAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPDsAsD |
| Q8NBP7 | S487 | Sugiyama | PCSK9 NARC1 PSEC0052 | PTRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKL |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8NE71 | S287 | Sugiyama | ABCF1 ABC50 | YERQVASLKAANAAENDFsVsQAEMSsRQAMLENASDIKLE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD19 | S868 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | LQGLKVAsEAPLEHKPQVEAssPRLNPAVtCAGKGtPLtPP |
| Q8TF05 | S57 | Sugiyama | PPP4R1 MEG1 PP4R1 | DFVSQDEMLTPLGRLDKyAAsENIFNRQMVARSLLDTLREV |
| Q8WVJ2 | S142 | Sugiyama | NUDCD2 | LTLERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK_____ |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q8WWM7 | S273 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRE |
| Q92928 | T64 | Sugiyama | RAB1C | DFKIQTIELDGKTIKLQIWDtAGQERFWTITSSYYRGAHGF |
| Q92930 | T64 | Sugiyama | RAB8B | DFKIRTIELDGKKIKLQIWDtAGQERFRtITTAYYRGAMGI |
| Q969M3 | S45 | Sugiyama | YIPF5 FINGER5 YIP1A PP12723 SB140 UNQ3123/PRO10275 | SYDYGGSGGPYSKQYAGyDysQQGRFVPPDMMQPQQPYTGQ |
| Q96AC1 | S666 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | VHEFIGGYIFLSTRAKDQNEsLDEEMFyKLTSGWV______ |
| Q96AE4 | S52 | Sugiyama | FUBP1 | KDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQ |
| Q96AG4 | S47 | Sugiyama | LRRC59 PRO1855 | LNEVPVKELAALPKATILDLsCNKLTTLPSDFCGLtHLVKL |
| Q96AP0 | S169 | SIGNOR|PSP | ACD PIP1 PTOP TINT1 TPP1 | YDCLEEHLSESTSSNAGLSLsQLLDEMREDQEHQGALVCLA |
| Q96AX2 | T86 | Sugiyama | RAB37 | DFRNKVVTVDGVRVKLQIWDtAGQERFRSVTHAYYRDAQAL |
| Q96D15 | S76 | Sugiyama | RCN3 UNQ239/PRO272 | HEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGDGDGW |
| Q96DA2 | T65 | Sugiyama | RAB39B | FFSRLVEIEPGKRIKLQIWDtAGQERFRSITRAYYRNSVGG |
| Q96E17 | T86 | Sugiyama | RAB3C | DFKVKTVFKNEKRIKLQIWDtAGQERYRtITTAYYRGAMGF |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | S71 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | ETIDRFNNYRLFPRLQKLLEsDyFRyyKVNLKRPCPFWNDI |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q96LD4 | S180 | Sugiyama | TRIM47 GOA RNF100 | ERSPALRGHRLVPPLRRLEEsLCPRHLRPLERYCRAERVCL |
| Q96QK1 | S760 | Sugiyama | VPS35 MEM3 TCCCTA00141 | IQVLNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRLR |
| Q96R06 | S716 | Sugiyama | SPAG5 | QVSAQLEECKGQTEQLELENsRLATDLRAQLQILANMDSQL |
| Q96S66 | S59 | Sugiyama | CLCC1 KIAA0761 MCLC | MRKSQAKYGISGEKDVSPDLsCADEIsECyHKLDSLTYKID |
| Q99426 | S76 | Sugiyama | TBCB CG22 CKAP1 | LYGVDDKFYsKLDQEDALLGsYPVDDGCRIHVIDHsGARLG |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99613 | S639 | Sugiyama | EIF3C EIF3S8 | CAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQERN |
| Q99615 | S94 | Sugiyama | DNAJC7 TPR2 TTC2 | MLGRFREALGDAQQsVRLDDsFVRGHLREGKCHLSLGNAMA |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q99832 | T458 | Sugiyama | CCT7 CCTH NIP7-1 | yAKALEIIPRQLCDNAGFDAtNILNKLRARHAQGGTWYGVD |
| Q99961 | S108 | Sugiyama | SH3GL1 CNSA1 SH3D2B | QSEGLLGECMIRHGKELGGEsNFGDALLDAGEsMKRLAEVK |
| Q99961 | S120 | Sugiyama | SH3GL1 CNSA1 SH3D2B | HGKELGGEsNFGDALLDAGEsMKRLAEVKDSLDIEVKQNFI |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BT78 | S18 | Sugiyama | COPS4 CSN4 | ___MAAAVRQDLAQLMNSsGsHKDLAGKYRQILEKAIQLSG |
| Q9BUJ2 | T507 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | CLNRLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRK |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BXP5 | S703 | Sugiyama | SRRT ARS2 ASR2 | EEAQKMGRKDPEQEVEKFVtsNtQELGKDKWLCPLsGKKFK |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C2 | S1173 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KttAGsVDWTDQLGLRNLEVssCVGsGGssEAREsAVGQMG |
| Q9GZZ9 | S24 | Sugiyama | UBA5 UBE1DC1 | SVERLQQRVQELERELAQERsLQVPRSGDGGGGRVRIEKMs |
| Q9H0U4 | T64 | Sugiyama | RAB1B | DFKIRTIELDGKTIKLQIWDtAGQERFRtItsSYYRGAHGI |
| Q9H147 | S210 | Sugiyama | DNTTIP1 C20orf167 TDIF1 | KSCEPIRREGPKWDPARLNEsTTFVLGSRANKALGMGGTRG |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H173 | Y126 | Sugiyama | SIL1 UNQ545/PRO836 | YEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMES |
| Q9H1H9 | S1753 | Sugiyama | KIF13A RBKIN | HsFTEFMGVSEGKDFDGLTDssAGELssRRsLPNKTGGKTV |
| Q9H2M9 | S455 | Sugiyama | RAB3GAP2 KIAA0839 | TVEDLHERVPEKADFsPFGNsQGPSRVAQFLVIYAPRRGIL |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H3N1 | S228 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | PSKRRRPQPYPYPSKKLLsEsAQPLKKVEEEQEADEEDVsE |
| Q9H6T3 | S348 | Sugiyama | RPAP3 | KIQKYEEAEKDCTQAILLDGsYSKAFARRGTARTFLGKLNE |
| Q9H788 | S187 | Sugiyama | SH2D4A PPP1R38 SH2A | EEKIRSLSSSSRNIQQMLADsINRMKAYAFHQKKESMKKKQ |
| Q9H788 | S317 | Sugiyama | SH2D4A PPP1R38 SH2A | SGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAGY |
| Q9HB07 | T193 | Sugiyama | MYG1 C12orf10 | DAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHPDQDT |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9HC35 | S144 | SIGNOR|PSP | EML4 C2orf2 EMAPL4 | GQREKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsK |
| Q9HC98 | S206 | Sugiyama | NEK6 | VKLGDLGLGRFFssEttAAHsLVGtPYYMSPERIHENGYNF |
| Q9HC98 | S312 | Sugiyama | NEK6 | QRPDIGYVHQVAKQMHIWMSst___________________ |
| Q9HC98 | S57 | Sugiyama | NEK6 | sFRCSLADFQIEKKIGRGQFsEVyKAtCLLDRKTVALKKVQ |
| Q9HC98 | T202 | Sugiyama | NEK6 | ATGVVKLGDLGLGRFFssEttAAHsLVGtPYYMSPERIHEN |
| Q9HC98 | T313 | Sugiyama | NEK6 | RPDIGYVHQVAKQMHIWMSst____________________ |
| Q9HC98 | T63 | Sugiyama | NEK6 | ADFQIEKKIGRGQFsEVyKAtCLLDRKTVALKKVQIFEMMD |
| Q9HC98 | Y60 | Sugiyama | NEK6 | CSLADFQIEKKIGRGQFsEVyKAtCLLDRKTVALKKVQIFE |
| Q9NP61 | S455 | Sugiyama | ARFGAP3 ARFGAP1 | RQsQADYETRARLERLsAsssIssADLFEEPRKQPAGNysL |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NQE9 | T47 | Sugiyama | HINT3 | ssVGTCEAAGKsPEPKDyDstCVFCRIAGRQDPGTELLHCE |
| Q9NQR4 | S137 | Sugiyama | NIT2 CUA002 | DIDVPGKITFQESKTLsPGDsFSTFDTPyCRVGLGICYDMR |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NUQ8 | S186 | Sugiyama | ABCF3 | RLESSGKNKSYDVRIENFDVsFGDRVLLAGADVNLAWGRRY |
| Q9NVA2 | S407 | Sugiyama | SEPTIN11 SEPT11 | ELEEEVNNFQKKKAAAQLLQsQAQQSGAQQTKKDKDKKNAS |
| Q9NY33 | S190 | Sugiyama | DPP3 | TYFSGNCTMEDAKLAQDFLDsQNLsAyNtRLFKEVDGEGKP |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9UBC2 | S518 | Sugiyama | EPS15L1 EPS15R | LNRAKSELNRLQQEETQLEQsIQAGRVQLETIIKSLKSTQD |
| Q9UGV2 | S349 | Sugiyama | NDRG3 | tHstsssLGsGEsPFsRsVtsNQsDGtQESCEsPDVLDRHQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UK45 | S16 | Sugiyama | LSM7 | _____MADKEKKKKEsILDLsKYIDKTIRVKFQGGREASGI |
| Q9UKK9 | S24 | Sugiyama | NUDT5 NUDIX5 HSPC115 | QEPtEssQNGKQyIISEELIsEGKWVKLEKTTYMDPTGKtR |
| Q9ULC3 | S186 | Sugiyama | RAB23 HSPC137 | AEKYLQKLKQQIAEDPELTHsssNKIGVFNtsGGsHsGQNs |
| Q9UNF0 | S273 | Sugiyama | PACSIN2 | KHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFRANHGPG |
| Q9UNX3 | S12 | Sugiyama | RPL26L1 RPL26P1 | _________MKFNPFVtsDRsKNRKRHFNAPSHVRRKIMss |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPN9 | S949 | Sugiyama | TRIM33 KIAA1113 RFG7 TIF1G | TFCRDIGKPEVEYDCDNLQHsKKGKTAQGLsPVDQRKCERL |
| Q9UPQ0 | S907 | Sugiyama | LIMCH1 KIAA1102 | TRESDRLEEKGsLTEGALAHsGNPVSKGVHEDHQLDTEAGA |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T60 | Sugiyama | PA2G4 EBP1 | ssGVsVLsLCEKGDAMIMEEtGKIFKKEKEMKKGIAFPTSI |
| Q9UQB8 | S336 | Sugiyama | BAIAP2 | RKAAQPKsLsPPQsQSKLSDsysNtLPVRKSVTPKNSYATt |
| Q9UQB8 | T340 | Sugiyama | BAIAP2 | QPKsLsPPQsQSKLSDsysNtLPVRKSVTPKNSYATtENKt |
| Q9UQB8 | Y337 | Sugiyama | BAIAP2 | KAAQPKsLsPPQsQSKLSDsysNtLPVRKSVTPKNSYATtE |
| Q9UQE7 | S886 | Sugiyama | SMC3 BAM BMH CSPG6 SMC3L1 | LEAINKRVKDTMARSEDLDNsIDKTEAGIKELQKSMERWKN |
| Q9Y265 | S29 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | TTKTQRIAsHSHVKGLGLDEsGLAKQAASGLVGQENAREAC |
| Q9Y295 | T194 | Sugiyama | DRG1 NEDD3 | SKPPNIGFKKKDKGGINLTAtCPQSELDAETVKSILAEyKI |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2X9 | S778 | Sugiyama | ZNF281 GZP1 ZBP99 | QLTPSQELDDLIDSQKNLEtsSAFQsssQKLTSQKEQKNLE |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3F4 | S228 | Sugiyama | STRAP MAWD UNRIP | FHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y450 | S65 | Sugiyama | HBS1L HBS1 KIAA1038 | RDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCL |
| Q9Y5K5 | S131 | Sugiyama | UCHL5 UCH37 AD-019 CGI-70 | LSEFKEFSQSFDAAMKGLALsNsDVIRQVHNSFARQQMFEF |
| Q9Y5X1 | S116 | Sugiyama | SNX9 SH3PX1 SH3PXD3A | SNNHQVGSGNDPWSAWSASKsGNWESsEGWGAQPEGAGAQR |
| Q9Y617 | S43 | Sugiyama | PSAT1 PSA | LEIQKELLDYKGVGIsVLEMsHRssDFAKIINNTENLVREL |
| Q9Y6D5 | S700 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | QFLHQEERLDSTQVGDFLGDsARFNKEVMYAYVDQLDFCEK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Mitotic Prometaphase | R-HSA-68877 | 1.657341e-12 | 11.781 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.148126e-12 | 11.382 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.808786e-11 | 10.743 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.417315e-10 | 9.849 | 1 | 1 |
| Attenuation phase | R-HSA-3371568 | 2.078206e-10 | 9.682 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.894599e-10 | 9.722 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.408778e-10 | 9.075 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.305530e-08 | 7.637 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.810326e-08 | 7.167 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.892807e-08 | 7.162 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.051432e-08 | 7.094 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.307258e-08 | 7.031 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.115768e-07 | 6.952 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.716725e-07 | 6.765 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.778956e-07 | 6.556 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.092727e-07 | 6.510 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.188195e-07 | 6.496 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.280321e-07 | 6.484 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.127543e-07 | 6.213 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.534166e-07 | 6.185 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.166979e-07 | 6.088 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.873161e-07 | 6.052 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.873161e-07 | 6.052 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.177290e-06 | 5.929 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.658138e-06 | 5.437 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.954680e-06 | 5.403 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.993885e-06 | 5.399 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.059308e-06 | 5.151 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.362942e-06 | 5.078 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.899890e-06 | 5.051 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.121761e-05 | 4.950 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.067534e-05 | 4.972 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.141135e-05 | 4.943 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.386407e-05 | 4.858 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.490344e-05 | 4.827 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.623793e-05 | 4.789 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.623793e-05 | 4.789 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.164714e-05 | 4.665 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.164714e-05 | 4.665 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.353778e-05 | 4.628 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.386782e-05 | 4.622 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.612018e-05 | 4.583 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.553140e-05 | 4.449 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.597262e-05 | 4.444 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.462385e-05 | 4.461 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.730096e-05 | 4.428 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.186495e-05 | 4.285 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.186495e-05 | 4.285 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.507414e-05 | 4.259 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.145607e-05 | 4.211 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.500267e-05 | 4.187 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.640631e-05 | 4.178 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.869415e-05 | 4.163 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.445791e-05 | 4.128 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.958094e-05 | 4.099 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.961138e-05 | 4.048 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.959772e-05 | 4.002 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.069766e-04 | 3.971 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.128438e-04 | 3.948 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.149423e-04 | 3.940 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.285676e-04 | 3.891 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.487176e-04 | 3.828 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.593455e-04 | 3.798 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.528331e-04 | 3.816 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.593455e-04 | 3.798 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.579355e-04 | 3.802 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.640111e-04 | 3.785 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.641501e-04 | 3.785 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.722671e-04 | 3.764 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.872066e-04 | 3.728 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.973941e-04 | 3.705 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.186656e-04 | 3.660 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.302758e-04 | 3.638 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.515550e-04 | 3.599 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.705999e-04 | 3.568 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.183591e-04 | 3.497 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.772687e-04 | 3.423 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.825455e-04 | 3.417 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.294978e-04 | 3.367 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.364838e-04 | 3.360 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.935384e-04 | 3.307 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.492911e-04 | 3.260 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.117516e-04 | 3.213 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.117516e-04 | 3.213 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.692756e-04 | 3.174 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.623534e-04 | 3.179 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.810264e-04 | 3.167 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.684055e-04 | 3.114 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.478485e-04 | 3.072 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.478485e-04 | 3.072 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.536347e-04 | 3.069 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.536347e-04 | 3.069 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.536347e-04 | 3.069 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.023012e-04 | 3.045 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.345019e-04 | 3.029 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.501433e-04 | 3.022 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.064129e-03 | 2.973 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.084452e-03 | 2.965 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.084452e-03 | 2.965 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.098630e-03 | 2.959 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.105868e-03 | 2.956 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.154703e-03 | 2.938 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.204894e-03 | 2.919 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.138850e-03 | 2.944 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.245662e-03 | 2.905 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.426427e-03 | 2.846 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.527641e-03 | 2.816 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.527641e-03 | 2.816 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.426427e-03 | 2.846 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.627075e-03 | 2.789 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.674450e-03 | 2.776 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.682055e-03 | 2.774 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.696629e-03 | 2.770 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.736892e-03 | 2.760 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.774566e-03 | 2.751 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.804823e-03 | 2.744 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.852106e-03 | 2.732 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.028729e-03 | 2.693 | 1 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.084806e-03 | 2.681 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.084806e-03 | 2.681 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.173300e-03 | 2.663 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.296353e-03 | 2.639 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.375927e-03 | 2.624 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.559703e-03 | 2.592 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.654782e-03 | 2.576 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.652615e-03 | 2.576 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.654782e-03 | 2.576 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.721996e-03 | 2.565 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.721996e-03 | 2.565 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.838636e-03 | 2.547 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.058037e-03 | 2.515 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.167788e-03 | 2.499 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.296288e-03 | 2.482 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.358076e-03 | 2.474 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.762469e-03 | 2.425 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.795865e-03 | 2.421 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.998049e-03 | 2.398 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.008049e-03 | 2.397 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.335186e-03 | 2.363 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.445449e-03 | 2.352 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.445449e-03 | 2.352 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.445449e-03 | 2.352 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.445449e-03 | 2.352 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.621965e-03 | 2.335 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.621965e-03 | 2.335 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.621965e-03 | 2.335 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.742098e-03 | 2.324 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.880417e-03 | 2.312 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.188391e-03 | 2.285 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.096711e-03 | 2.293 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.525403e-03 | 2.258 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.621538e-03 | 2.250 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.853107e-03 | 2.233 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.922910e-03 | 2.227 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.926156e-03 | 2.227 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.996067e-03 | 2.222 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.113883e-03 | 2.214 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.176851e-03 | 2.209 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.176851e-03 | 2.209 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.249923e-03 | 2.204 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.542902e-03 | 2.184 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.621516e-03 | 2.179 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.758863e-03 | 2.170 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.758863e-03 | 2.170 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 7.517207e-03 | 2.124 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.970453e-03 | 2.157 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.970453e-03 | 2.157 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.970453e-03 | 2.157 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.703757e-03 | 2.113 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.703757e-03 | 2.113 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.949763e-03 | 2.100 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.102143e-03 | 2.091 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.321355e-03 | 2.080 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.578866e-03 | 2.067 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.578866e-03 | 2.067 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.500464e-03 | 2.022 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.776697e-03 | 2.010 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.872949e-03 | 2.006 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.872949e-03 | 2.006 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.037833e-02 | 1.984 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.094753e-02 | 1.961 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.799968e-03 | 2.009 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.102304e-02 | 1.958 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.057150e-02 | 1.976 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.050436e-02 | 1.979 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.050436e-02 | 1.979 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.045763e-02 | 1.981 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.872949e-03 | 2.006 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.104368e-02 | 1.957 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.122462e-02 | 1.950 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.148461e-02 | 1.940 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.148461e-02 | 1.940 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.164152e-02 | 1.934 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.170036e-02 | 1.932 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.222096e-02 | 1.913 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.246958e-02 | 1.904 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.249964e-02 | 1.903 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.253161e-02 | 1.902 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.256514e-02 | 1.901 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.262858e-02 | 1.899 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.473614e-02 | 1.832 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.473614e-02 | 1.832 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.473614e-02 | 1.832 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.473614e-02 | 1.832 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.473614e-02 | 1.832 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.375294e-02 | 1.862 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.295460e-02 | 1.888 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.295460e-02 | 1.888 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.295460e-02 | 1.888 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.446054e-02 | 1.840 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.364309e-02 | 1.865 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.366907e-02 | 1.864 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.499959e-02 | 1.824 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.545643e-02 | 1.811 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.552579e-02 | 1.809 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.553908e-02 | 1.809 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.623104e-02 | 1.790 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.707434e-02 | 1.768 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.720424e-02 | 1.764 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.720424e-02 | 1.764 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.720424e-02 | 1.764 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.720424e-02 | 1.764 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.720424e-02 | 1.764 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.720424e-02 | 1.764 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.720424e-02 | 1.764 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.720424e-02 | 1.764 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.720424e-02 | 1.764 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.954536e-02 | 1.709 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.954536e-02 | 1.709 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.921008e-02 | 1.716 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.909549e-02 | 1.719 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.984944e-02 | 1.702 | 1 | 1 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.071710e-02 | 1.684 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.798414e-02 | 1.745 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.984944e-02 | 1.702 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.909549e-02 | 1.719 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.053843e-02 | 1.687 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.836987e-02 | 1.736 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.954536e-02 | 1.709 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.874524e-02 | 1.727 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.121145e-02 | 1.673 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.123318e-02 | 1.673 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.123318e-02 | 1.673 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.232496e-02 | 1.651 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.232496e-02 | 1.651 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.239482e-02 | 1.650 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.282824e-02 | 1.642 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.304163e-02 | 1.637 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.304163e-02 | 1.637 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.321510e-02 | 1.634 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.321510e-02 | 1.634 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.321510e-02 | 1.634 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.336506e-02 | 1.631 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.336506e-02 | 1.631 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.465836e-02 | 1.608 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.484060e-02 | 1.605 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.484060e-02 | 1.605 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.579708e-02 | 1.588 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.592406e-02 | 1.586 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.695404e-02 | 1.569 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.695404e-02 | 1.569 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.695404e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.695404e-02 | 1.569 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.695404e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.695404e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.695404e-02 | 1.569 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.700902e-02 | 1.568 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.771931e-02 | 1.557 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.841779e-02 | 1.546 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.841779e-02 | 1.546 | 1 | 1 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.841779e-02 | 1.546 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.397549e-02 | 1.469 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.397549e-02 | 1.469 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.397549e-02 | 1.469 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.397549e-02 | 1.469 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.838303e-02 | 1.547 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.838303e-02 | 1.547 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.339893e-02 | 1.476 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.217876e-02 | 1.492 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.339893e-02 | 1.476 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.889559e-02 | 1.539 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.180887e-02 | 1.497 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.855734e-02 | 1.544 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.872132e-02 | 1.542 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.838303e-02 | 1.547 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.872132e-02 | 1.542 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.485109e-02 | 1.458 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.485200e-02 | 1.458 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.485200e-02 | 1.458 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.485200e-02 | 1.458 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.501365e-02 | 1.456 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.501365e-02 | 1.456 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.543396e-02 | 1.451 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.543396e-02 | 1.451 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.543396e-02 | 1.451 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.543396e-02 | 1.451 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.557317e-02 | 1.449 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.571240e-02 | 1.447 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.597872e-02 | 1.444 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.634753e-02 | 1.440 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.634753e-02 | 1.440 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.768155e-02 | 1.424 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.837140e-02 | 1.416 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.877476e-02 | 1.411 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.923172e-02 | 1.406 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.933474e-02 | 1.405 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.933474e-02 | 1.405 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.933474e-02 | 1.405 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.959491e-02 | 1.402 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.959491e-02 | 1.402 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.959491e-02 | 1.402 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.959491e-02 | 1.402 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.959491e-02 | 1.402 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.959491e-02 | 1.402 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.021955e-02 | 1.396 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.142663e-02 | 1.383 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.142663e-02 | 1.383 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.142663e-02 | 1.383 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.179025e-02 | 1.379 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.179025e-02 | 1.379 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.179025e-02 | 1.379 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.179025e-02 | 1.379 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.179025e-02 | 1.379 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.208610e-02 | 1.376 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.342107e-02 | 1.362 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.342107e-02 | 1.362 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.342107e-02 | 1.362 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.352144e-02 | 1.361 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.459114e-02 | 1.351 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 5.588325e-02 | 1.253 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 5.588325e-02 | 1.253 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.232710e-02 | 1.281 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.267663e-02 | 1.278 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.979671e-02 | 1.303 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.038624e-02 | 1.298 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.038624e-02 | 1.298 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.038624e-02 | 1.298 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.039686e-02 | 1.298 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.501324e-02 | 1.347 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.532697e-02 | 1.257 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.168839e-02 | 1.287 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.429327e-02 | 1.265 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.232710e-02 | 1.281 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.091549e-02 | 1.293 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.429327e-02 | 1.265 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.501324e-02 | 1.347 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.609013e-02 | 1.251 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.947759e-02 | 1.306 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.153026e-02 | 1.288 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.511029e-02 | 1.346 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.224118e-02 | 1.282 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.646103e-02 | 1.248 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.655097e-02 | 1.248 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.820401e-02 | 1.235 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.820401e-02 | 1.235 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.933450e-02 | 1.227 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.009833e-02 | 1.221 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.009833e-02 | 1.221 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.009833e-02 | 1.221 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.104031e-02 | 1.214 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.132180e-02 | 1.212 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.138546e-02 | 1.212 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.284635e-02 | 1.202 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.284635e-02 | 1.202 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.284635e-02 | 1.202 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.284635e-02 | 1.202 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.284635e-02 | 1.202 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.300301e-02 | 1.201 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.300301e-02 | 1.201 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.329429e-02 | 1.199 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.713488e-02 | 1.173 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.716330e-02 | 1.173 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.737345e-02 | 1.172 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.737345e-02 | 1.172 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.737345e-02 | 1.172 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.084749e-02 | 1.150 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.084749e-02 | 1.150 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.099253e-02 | 1.149 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.099253e-02 | 1.149 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.099253e-02 | 1.149 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.106798e-02 | 1.148 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.227097e-02 | 1.141 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.519633e-02 | 1.124 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.663064e-02 | 1.116 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.751968e-02 | 1.111 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.751968e-02 | 1.111 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.751968e-02 | 1.111 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.751968e-02 | 1.111 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.778202e-02 | 1.109 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.894606e-02 | 1.103 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.894606e-02 | 1.103 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.894606e-02 | 1.103 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.894606e-02 | 1.103 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.965355e-02 | 1.099 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.965355e-02 | 1.099 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.976482e-02 | 1.098 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.976482e-02 | 1.098 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.976482e-02 | 1.098 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.976482e-02 | 1.098 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.976482e-02 | 1.098 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.032961e-02 | 1.095 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.049065e-02 | 1.094 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.201164e-02 | 1.086 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 8.201164e-02 | 1.086 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.068244e-01 | 0.971 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.440685e-02 | 1.074 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.033223e-01 | 0.986 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.666787e-02 | 1.062 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.001508e-01 | 0.999 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.001508e-01 | 0.999 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.001508e-01 | 0.999 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.014894e-01 | 0.994 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.991788e-02 | 1.046 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.009096e-01 | 0.996 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.009096e-01 | 0.996 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.919223e-02 | 1.004 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.029360e-01 | 0.987 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.914581e-02 | 1.050 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.998967e-02 | 1.000 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.919223e-02 | 1.004 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.666787e-02 | 1.062 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.440685e-02 | 1.074 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.419172e-02 | 1.075 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.542621e-02 | 1.020 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.542621e-02 | 1.020 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.542621e-02 | 1.020 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.542621e-02 | 1.020 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.436645e-02 | 1.074 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.915936e-02 | 1.004 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.711640e-02 | 1.013 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.454504e-02 | 1.073 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.916530e-02 | 1.050 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.078481e-01 | 0.967 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.855701e-02 | 1.006 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.065320e-01 | 0.973 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.419172e-02 | 1.075 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.133550e-02 | 1.090 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.797506e-02 | 1.056 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.542621e-02 | 1.020 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.769493e-02 | 1.010 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.759326e-02 | 1.058 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.991788e-02 | 1.046 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.811145e-02 | 1.008 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.601774e-02 | 1.018 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.267441e-02 | 1.033 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.162938e-02 | 1.038 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.936209e-02 | 1.049 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.034901e-01 | 0.985 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.014894e-01 | 0.994 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.550453e-02 | 1.068 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.201164e-02 | 1.086 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.991788e-02 | 1.046 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.093724e-01 | 0.961 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.098400e-01 | 0.959 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.099020e-01 | 0.959 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.118937e-01 | 0.951 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.118937e-01 | 0.951 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.119504e-01 | 0.951 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.144642e-01 | 0.941 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.144642e-01 | 0.941 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.146691e-01 | 0.941 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.185540e-01 | 0.926 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.185540e-01 | 0.926 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.185540e-01 | 0.926 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.185540e-01 | 0.926 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.185540e-01 | 0.926 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.197901e-01 | 0.922 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.210993e-01 | 0.917 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.239840e-01 | 0.907 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.240693e-01 | 0.906 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.250292e-01 | 0.903 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.250292e-01 | 0.903 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.250292e-01 | 0.903 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.257085e-01 | 0.901 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.282620e-01 | 0.892 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.282620e-01 | 0.892 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.282620e-01 | 0.892 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.282620e-01 | 0.892 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.296054e-01 | 0.887 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.301826e-01 | 0.885 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.301826e-01 | 0.885 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.321710e-01 | 0.879 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.321710e-01 | 0.879 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.321710e-01 | 0.879 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.321710e-01 | 0.879 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.321710e-01 | 0.879 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.325648e-01 | 0.878 | 1 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.327347e-01 | 0.877 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.329571e-01 | 0.876 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.341484e-01 | 0.872 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.341484e-01 | 0.872 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.341484e-01 | 0.872 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.341484e-01 | 0.872 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.341484e-01 | 0.872 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.341484e-01 | 0.872 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.381219e-01 | 0.860 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.385139e-01 | 0.859 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.391595e-01 | 0.856 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.394042e-01 | 0.856 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.428517e-01 | 0.845 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.428517e-01 | 0.845 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.428517e-01 | 0.845 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.428517e-01 | 0.845 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.431276e-01 | 0.844 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.451932e-01 | 0.838 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.453970e-01 | 0.837 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.462328e-01 | 0.835 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.462328e-01 | 0.835 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.462328e-01 | 0.835 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.466417e-01 | 0.834 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 1.466417e-01 | 0.834 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.470422e-01 | 0.833 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.470422e-01 | 0.833 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.470422e-01 | 0.833 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.508154e-01 | 0.822 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.518721e-01 | 0.819 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.530735e-01 | 0.815 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.546887e-01 | 0.811 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.548594e-01 | 0.810 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 2.230591e-01 | 0.652 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.230591e-01 | 0.652 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.230591e-01 | 0.652 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 2.230591e-01 | 0.652 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.230591e-01 | 0.652 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.230591e-01 | 0.652 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.230591e-01 | 0.652 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.230591e-01 | 0.652 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.230591e-01 | 0.652 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.230591e-01 | 0.652 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.758700e-01 | 0.755 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.758700e-01 | 0.755 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.758700e-01 | 0.755 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.214086e-01 | 0.655 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.214086e-01 | 0.655 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.214086e-01 | 0.655 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.214086e-01 | 0.655 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.635750e-01 | 0.786 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.635750e-01 | 0.786 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.635750e-01 | 0.786 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.946934e-01 | 0.711 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.946934e-01 | 0.711 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.946934e-01 | 0.711 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.271051e-01 | 0.644 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.271051e-01 | 0.644 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.271051e-01 | 0.644 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.271051e-01 | 0.644 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.271051e-01 | 0.644 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.684713e-01 | 0.773 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.684713e-01 | 0.773 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.206941e-01 | 0.656 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.206941e-01 | 0.656 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.639887e-01 | 0.785 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.639887e-01 | 0.785 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.639887e-01 | 0.785 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.581965e-01 | 0.801 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.581965e-01 | 0.801 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.821594e-01 | 0.740 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.821594e-01 | 0.740 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.112493e-01 | 0.675 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.112493e-01 | 0.675 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.818701e-01 | 0.740 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.932873e-01 | 0.714 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.305499e-01 | 0.637 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.899571e-01 | 0.721 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.777585e-01 | 0.750 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.777585e-01 | 0.750 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.162681e-01 | 0.665 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.731665e-01 | 0.762 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.777585e-01 | 0.750 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.889082e-01 | 0.724 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.889082e-01 | 0.724 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.162681e-01 | 0.665 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.626683e-01 | 0.789 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.742540e-01 | 0.759 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.049415e-01 | 0.688 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.338264e-01 | 0.631 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.338264e-01 | 0.631 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.961629e-01 | 0.707 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.206941e-01 | 0.656 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.271051e-01 | 0.644 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.206864e-01 | 0.656 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.636577e-01 | 0.786 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.946934e-01 | 0.711 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.698929e-01 | 0.770 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.290787e-01 | 0.640 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.155360e-01 | 0.666 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.028545e-01 | 0.693 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.698929e-01 | 0.770 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.133234e-01 | 0.671 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.662511e-01 | 0.779 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.961009e-01 | 0.708 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.662511e-01 | 0.779 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.010834e-01 | 0.697 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.581965e-01 | 0.801 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.759638e-01 | 0.755 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.913423e-01 | 0.718 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.262162e-01 | 0.645 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.230591e-01 | 0.652 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.946934e-01 | 0.711 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.946934e-01 | 0.711 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.812267e-01 | 0.742 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.719131e-01 | 0.765 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.214086e-01 | 0.655 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.214086e-01 | 0.655 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.010834e-01 | 0.697 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.806681e-01 | 0.743 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.214086e-01 | 0.655 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.338264e-01 | 0.631 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.382163e-01 | 0.623 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.400313e-01 | 0.620 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.408903e-01 | 0.618 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.408903e-01 | 0.618 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.420922e-01 | 0.616 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.438088e-01 | 0.613 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.440754e-01 | 0.612 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.452790e-01 | 0.610 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.452790e-01 | 0.610 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.463391e-01 | 0.608 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.467650e-01 | 0.608 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.467650e-01 | 0.608 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.467650e-01 | 0.608 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.151793e-01 | 0.501 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.151793e-01 | 0.501 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.151793e-01 | 0.501 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.151793e-01 | 0.501 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.151793e-01 | 0.501 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.151793e-01 | 0.501 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.151793e-01 | 0.501 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 2.677373e-01 | 0.572 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.677373e-01 | 0.572 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.677373e-01 | 0.572 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.677373e-01 | 0.572 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.677373e-01 | 0.572 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.963818e-01 | 0.402 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.963818e-01 | 0.402 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.963818e-01 | 0.402 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.963818e-01 | 0.402 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective visual phototransduction due to STRA6 loss of function | R-HSA-9918449 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.963818e-01 | 0.402 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.963818e-01 | 0.402 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.963818e-01 | 0.402 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.963818e-01 | 0.402 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.963818e-01 | 0.402 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.140289e-01 | 0.503 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.140289e-01 | 0.503 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.140289e-01 | 0.503 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.140289e-01 | 0.503 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.140289e-01 | 0.503 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.140289e-01 | 0.503 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.604327e-01 | 0.584 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.943268e-01 | 0.531 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.943268e-01 | 0.531 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.943268e-01 | 0.531 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.596416e-01 | 0.444 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.596416e-01 | 0.444 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.596416e-01 | 0.444 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.596416e-01 | 0.444 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.596416e-01 | 0.444 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.596416e-01 | 0.444 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.679598e-01 | 0.330 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.679598e-01 | 0.330 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.679598e-01 | 0.330 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.679598e-01 | 0.330 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.679598e-01 | 0.330 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.679598e-01 | 0.330 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.679598e-01 | 0.330 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.748539e-01 | 0.561 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.748539e-01 | 0.561 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.284694e-01 | 0.484 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.284694e-01 | 0.484 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.284694e-01 | 0.484 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.284694e-01 | 0.484 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.284694e-01 | 0.484 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.570397e-01 | 0.590 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.040856e-01 | 0.394 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.040856e-01 | 0.394 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.040856e-01 | 0.394 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.807714e-01 | 0.552 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.625764e-01 | 0.441 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.308790e-01 | 0.480 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.308790e-01 | 0.480 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.308790e-01 | 0.480 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.293257e-01 | 0.482 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.591586e-01 | 0.445 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.591586e-01 | 0.445 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.963976e-01 | 0.402 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.963976e-01 | 0.402 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.469971e-01 | 0.350 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.469971e-01 | 0.350 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.469971e-01 | 0.350 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.261024e-01 | 0.487 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.539242e-01 | 0.451 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.297164e-01 | 0.367 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.926198e-01 | 0.534 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.785949e-01 | 0.422 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.421283e-01 | 0.466 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.154844e-01 | 0.381 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.154844e-01 | 0.381 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.154844e-01 | 0.381 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.881148e-01 | 0.311 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.881148e-01 | 0.311 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.881148e-01 | 0.311 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.246875e-01 | 0.489 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.032384e-01 | 0.394 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.623484e-01 | 0.335 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.623484e-01 | 0.335 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.623484e-01 | 0.335 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.623484e-01 | 0.335 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.035976e-01 | 0.518 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.432619e-01 | 0.353 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.432619e-01 | 0.353 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.652225e-01 | 0.437 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.652225e-01 | 0.437 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.438089e-01 | 0.464 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.706255e-01 | 0.327 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.941396e-01 | 0.306 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.300242e-01 | 0.367 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.030402e-01 | 0.395 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.818348e-01 | 0.418 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.988509e-01 | 0.399 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.487737e-01 | 0.348 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.288750e-01 | 0.368 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.288750e-01 | 0.368 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.989510e-01 | 0.399 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.989510e-01 | 0.399 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.683429e-01 | 0.329 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.562353e-01 | 0.448 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.300242e-01 | 0.367 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.082601e-01 | 0.511 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.625764e-01 | 0.441 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.881148e-01 | 0.311 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.353407e-01 | 0.361 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.827797e-01 | 0.549 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.112123e-01 | 0.386 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.043023e-01 | 0.517 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.807714e-01 | 0.552 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.469971e-01 | 0.350 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.623484e-01 | 0.335 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.435227e-01 | 0.353 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.943268e-01 | 0.531 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.874074e-01 | 0.412 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.028668e-01 | 0.395 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.941396e-01 | 0.306 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.145256e-01 | 0.382 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.146587e-01 | 0.502 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.040856e-01 | 0.394 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.220965e-01 | 0.492 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.974745e-01 | 0.303 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.634709e-01 | 0.579 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.741228e-01 | 0.562 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.180824e-01 | 0.379 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.540374e-01 | 0.343 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.596416e-01 | 0.444 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.596416e-01 | 0.444 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.807714e-01 | 0.552 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.481005e-01 | 0.458 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.881148e-01 | 0.311 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.008877e-01 | 0.397 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.825705e-01 | 0.417 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.748539e-01 | 0.561 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.595647e-01 | 0.586 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.493137e-01 | 0.457 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.937210e-01 | 0.405 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.827074e-01 | 0.549 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.785949e-01 | 0.422 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.138208e-01 | 0.503 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.838124e-01 | 0.315 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.361897e-01 | 0.473 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.963976e-01 | 0.402 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.993957e-01 | 0.524 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.361897e-01 | 0.473 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.361897e-01 | 0.473 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.939721e-01 | 0.532 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.245032e-01 | 0.489 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.827797e-01 | 0.549 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.623484e-01 | 0.335 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.753466e-01 | 0.560 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.596416e-01 | 0.444 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.040856e-01 | 0.394 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.591586e-01 | 0.445 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.469971e-01 | 0.350 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.085543e-01 | 0.511 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.627293e-01 | 0.580 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.435556e-01 | 0.464 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.793356e-01 | 0.554 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.736403e-01 | 0.325 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.604327e-01 | 0.584 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.365742e-01 | 0.360 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 2.604327e-01 | 0.584 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.943268e-01 | 0.531 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.881148e-01 | 0.311 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.584671e-01 | 0.339 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.917550e-01 | 0.308 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.603886e-01 | 0.584 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.225666e-01 | 0.491 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.783086e-01 | 0.555 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.702194e-01 | 0.432 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.432619e-01 | 0.353 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.604465e-01 | 0.337 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.032134e-01 | 0.518 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.634150e-01 | 0.334 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.807714e-01 | 0.552 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.739602e-01 | 0.427 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.061692e-01 | 0.514 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.151793e-01 | 0.501 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.151793e-01 | 0.501 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.151793e-01 | 0.501 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.963818e-01 | 0.402 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.140289e-01 | 0.503 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.596416e-01 | 0.444 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.679598e-01 | 0.330 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 4.679598e-01 | 0.330 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.634709e-01 | 0.579 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.469971e-01 | 0.350 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.889275e-01 | 0.539 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.548230e-01 | 0.450 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.739602e-01 | 0.427 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.483812e-01 | 0.458 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.686814e-01 | 0.433 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.997779e-01 | 0.301 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.677628e-01 | 0.572 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.433394e-01 | 0.353 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.349677e-01 | 0.362 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.867424e-01 | 0.313 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.481005e-01 | 0.458 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.706255e-01 | 0.327 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.748539e-01 | 0.561 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.604327e-01 | 0.584 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.994444e-01 | 0.524 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.297164e-01 | 0.367 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.702194e-01 | 0.432 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.096382e-01 | 0.509 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.573441e-01 | 0.589 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.741228e-01 | 0.562 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.548230e-01 | 0.450 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.246875e-01 | 0.489 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.623484e-01 | 0.335 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.600219e-01 | 0.585 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.332419e-01 | 0.363 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.677373e-01 | 0.572 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.040856e-01 | 0.394 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.625764e-01 | 0.441 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.469971e-01 | 0.350 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.022695e-01 | 0.520 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.028668e-01 | 0.395 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.879689e-01 | 0.411 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.596416e-01 | 0.444 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.469971e-01 | 0.350 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.022695e-01 | 0.520 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.972328e-01 | 0.401 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.151793e-01 | 0.501 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.151793e-01 | 0.501 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.963818e-01 | 0.402 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.679598e-01 | 0.330 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 2.616152e-01 | 0.582 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.625764e-01 | 0.441 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.154844e-01 | 0.381 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.032384e-01 | 0.394 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.277613e-01 | 0.369 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.828030e-01 | 0.417 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.807714e-01 | 0.552 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.761451e-01 | 0.322 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.181387e-01 | 0.379 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.597001e-01 | 0.338 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.302894e-01 | 0.366 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.625764e-01 | 0.441 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.188945e-01 | 0.496 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.679598e-01 | 0.330 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.469971e-01 | 0.350 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.297164e-01 | 0.367 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.297164e-01 | 0.367 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.974745e-01 | 0.303 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 2.677373e-01 | 0.572 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.596416e-01 | 0.444 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.637097e-01 | 0.579 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.926198e-01 | 0.534 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.881148e-01 | 0.311 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.249770e-01 | 0.488 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.357099e-01 | 0.361 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.689975e-01 | 0.433 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.904242e-01 | 0.408 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.623056e-01 | 0.441 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.706255e-01 | 0.327 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.487737e-01 | 0.348 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.677373e-01 | 0.572 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.963976e-01 | 0.402 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.469971e-01 | 0.350 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.297164e-01 | 0.367 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.432619e-01 | 0.353 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.584671e-01 | 0.339 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.226383e-01 | 0.374 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.974745e-01 | 0.303 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.015538e-01 | 0.300 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.881148e-01 | 0.311 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.018857e-01 | 0.299 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.030133e-01 | 0.298 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.088630e-01 | 0.293 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.097986e-01 | 0.293 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.132760e-01 | 0.290 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.132760e-01 | 0.290 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.132760e-01 | 0.290 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.224524e-01 | 0.282 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.226221e-01 | 0.282 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.226427e-01 | 0.282 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.229682e-01 | 0.282 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.237211e-01 | 0.281 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.237211e-01 | 0.281 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.249640e-01 | 0.280 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.249640e-01 | 0.280 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.249640e-01 | 0.280 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.272607e-01 | 0.278 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.272607e-01 | 0.278 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.272607e-01 | 0.278 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.272607e-01 | 0.278 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.272607e-01 | 0.278 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.310537e-01 | 0.275 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.310537e-01 | 0.275 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.310537e-01 | 0.275 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.310537e-01 | 0.275 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.310537e-01 | 0.275 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.310537e-01 | 0.275 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.310537e-01 | 0.275 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.310537e-01 | 0.275 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.310537e-01 | 0.275 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.310537e-01 | 0.275 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.310537e-01 | 0.275 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.310537e-01 | 0.275 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.310537e-01 | 0.275 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.361280e-01 | 0.271 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.364043e-01 | 0.271 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.382002e-01 | 0.269 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.389670e-01 | 0.268 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.390017e-01 | 0.268 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.402750e-01 | 0.267 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.433664e-01 | 0.265 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.433664e-01 | 0.265 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.457929e-01 | 0.263 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.492903e-01 | 0.260 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.508044e-01 | 0.259 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.547216e-01 | 0.256 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.547216e-01 | 0.256 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.547216e-01 | 0.256 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.547216e-01 | 0.256 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 5.547216e-01 | 0.256 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.578941e-01 | 0.253 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.643243e-01 | 0.248 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.643243e-01 | 0.248 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.643243e-01 | 0.248 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.643243e-01 | 0.248 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.643243e-01 | 0.248 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.645062e-01 | 0.248 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.658540e-01 | 0.247 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.680290e-01 | 0.246 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.680290e-01 | 0.246 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.697973e-01 | 0.244 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.741191e-01 | 0.241 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.741191e-01 | 0.241 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.741191e-01 | 0.241 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.780457e-01 | 0.238 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.805102e-01 | 0.236 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.833358e-01 | 0.234 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.833358e-01 | 0.234 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.833358e-01 | 0.234 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.833358e-01 | 0.234 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.833358e-01 | 0.234 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.833358e-01 | 0.234 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.835594e-01 | 0.234 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.835594e-01 | 0.234 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.847666e-01 | 0.233 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.854922e-01 | 0.232 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.866687e-01 | 0.232 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.866687e-01 | 0.232 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.866687e-01 | 0.232 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.866687e-01 | 0.232 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.866687e-01 | 0.232 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.866687e-01 | 0.232 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.866687e-01 | 0.232 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.866687e-01 | 0.232 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.866687e-01 | 0.232 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.866687e-01 | 0.232 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.866687e-01 | 0.232 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.866687e-01 | 0.232 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.866687e-01 | 0.232 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.866687e-01 | 0.232 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.896906e-01 | 0.229 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.896906e-01 | 0.229 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.923290e-01 | 0.227 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.930839e-01 | 0.227 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.955895e-01 | 0.225 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.968331e-01 | 0.224 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.981560e-01 | 0.223 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.981560e-01 | 0.223 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.992490e-01 | 0.222 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.992490e-01 | 0.222 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.992490e-01 | 0.222 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.992490e-01 | 0.222 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.992490e-01 | 0.222 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.992490e-01 | 0.222 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.992490e-01 | 0.222 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.029606e-01 | 0.220 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.075942e-01 | 0.216 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.088961e-01 | 0.215 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.088961e-01 | 0.215 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.107410e-01 | 0.214 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.107505e-01 | 0.214 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.107505e-01 | 0.214 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.155811e-01 | 0.211 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.213599e-01 | 0.207 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.213599e-01 | 0.207 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.213599e-01 | 0.207 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.218601e-01 | 0.206 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.226598e-01 | 0.206 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.249888e-01 | 0.204 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.252065e-01 | 0.204 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.268828e-01 | 0.203 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.319132e-01 | 0.199 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.319132e-01 | 0.199 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.320207e-01 | 0.199 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 6.320207e-01 | 0.199 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.320207e-01 | 0.199 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.320207e-01 | 0.199 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.320207e-01 | 0.199 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.320207e-01 | 0.199 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.320207e-01 | 0.199 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.320207e-01 | 0.199 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.320207e-01 | 0.199 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.325156e-01 | 0.199 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.356907e-01 | 0.197 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.356907e-01 | 0.197 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.356907e-01 | 0.197 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.356907e-01 | 0.197 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.356907e-01 | 0.197 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.356907e-01 | 0.197 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.356907e-01 | 0.197 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.356907e-01 | 0.197 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.356907e-01 | 0.197 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.356907e-01 | 0.197 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.356907e-01 | 0.197 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.356907e-01 | 0.197 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.356907e-01 | 0.197 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.356907e-01 | 0.197 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.369285e-01 | 0.196 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.369285e-01 | 0.196 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.369285e-01 | 0.196 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.369285e-01 | 0.196 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.390558e-01 | 0.194 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.411416e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.436998e-01 | 0.191 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.436998e-01 | 0.191 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.437822e-01 | 0.191 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.459924e-01 | 0.190 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.497053e-01 | 0.187 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.508926e-01 | 0.186 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.508926e-01 | 0.186 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.516624e-01 | 0.186 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.545103e-01 | 0.184 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.550196e-01 | 0.184 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.566868e-01 | 0.183 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.618484e-01 | 0.179 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.618484e-01 | 0.179 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.618484e-01 | 0.179 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.626588e-01 | 0.179 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.626588e-01 | 0.179 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.626588e-01 | 0.179 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.626588e-01 | 0.179 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.626588e-01 | 0.179 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.626588e-01 | 0.179 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.626588e-01 | 0.179 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.651534e-01 | 0.177 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.651534e-01 | 0.177 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.651534e-01 | 0.177 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.753140e-01 | 0.170 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.783528e-01 | 0.169 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.789012e-01 | 0.168 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.789012e-01 | 0.168 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.789012e-01 | 0.168 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.789012e-01 | 0.168 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.789012e-01 | 0.168 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.789012e-01 | 0.168 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.789012e-01 | 0.168 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.789012e-01 | 0.168 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.789012e-01 | 0.168 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.789012e-01 | 0.168 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.789012e-01 | 0.168 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.789012e-01 | 0.168 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.789012e-01 | 0.168 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.789012e-01 | 0.168 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.809999e-01 | 0.167 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.855030e-01 | 0.164 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.855030e-01 | 0.164 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.857067e-01 | 0.164 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.857067e-01 | 0.164 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.865592e-01 | 0.163 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.883105e-01 | 0.162 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.883105e-01 | 0.162 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.907875e-01 | 0.161 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.912084e-01 | 0.160 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.912084e-01 | 0.160 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.912084e-01 | 0.160 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.912084e-01 | 0.160 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.912084e-01 | 0.160 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.912084e-01 | 0.160 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.912084e-01 | 0.160 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.912084e-01 | 0.160 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.920361e-01 | 0.160 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.945897e-01 | 0.158 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.963164e-01 | 0.157 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.963164e-01 | 0.157 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.021451e-01 | 0.154 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.029514e-01 | 0.153 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.053531e-01 | 0.152 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.053531e-01 | 0.152 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.059633e-01 | 0.151 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.078970e-01 | 0.150 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.078970e-01 | 0.150 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.078970e-01 | 0.150 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.149107e-01 | 0.146 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.169888e-01 | 0.144 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.169888e-01 | 0.144 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.169888e-01 | 0.144 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.169888e-01 | 0.144 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.169888e-01 | 0.144 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.169888e-01 | 0.144 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.169888e-01 | 0.144 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.169888e-01 | 0.144 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.169888e-01 | 0.144 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.169888e-01 | 0.144 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.169888e-01 | 0.144 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.169888e-01 | 0.144 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.169888e-01 | 0.144 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.169888e-01 | 0.144 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.177339e-01 | 0.144 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.177339e-01 | 0.144 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.177339e-01 | 0.144 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.177339e-01 | 0.144 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.177339e-01 | 0.144 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.177339e-01 | 0.144 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.177339e-01 | 0.144 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.193417e-01 | 0.143 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.222823e-01 | 0.141 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.240924e-01 | 0.140 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.240924e-01 | 0.140 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.240924e-01 | 0.140 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.290451e-01 | 0.137 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.290451e-01 | 0.137 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.348196e-01 | 0.134 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.412074e-01 | 0.130 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.419301e-01 | 0.130 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.423136e-01 | 0.129 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.423136e-01 | 0.129 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.423136e-01 | 0.129 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.423136e-01 | 0.129 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.423136e-01 | 0.129 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.423136e-01 | 0.129 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.423136e-01 | 0.129 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.423136e-01 | 0.129 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 7.423136e-01 | 0.129 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.449754e-01 | 0.128 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.479507e-01 | 0.126 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.489708e-01 | 0.126 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.489708e-01 | 0.126 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.505604e-01 | 0.125 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.505604e-01 | 0.125 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.505604e-01 | 0.125 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.505604e-01 | 0.125 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.505604e-01 | 0.125 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.505604e-01 | 0.125 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.505604e-01 | 0.125 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.505604e-01 | 0.125 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.505604e-01 | 0.125 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.505604e-01 | 0.125 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.505604e-01 | 0.125 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.505604e-01 | 0.125 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.505604e-01 | 0.125 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.519172e-01 | 0.124 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.528957e-01 | 0.123 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.546566e-01 | 0.122 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.572763e-01 | 0.121 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.588769e-01 | 0.120 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.588769e-01 | 0.120 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.621313e-01 | 0.118 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.650358e-01 | 0.116 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.650358e-01 | 0.116 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.657905e-01 | 0.116 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.657905e-01 | 0.116 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.677040e-01 | 0.115 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.677040e-01 | 0.115 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.694767e-01 | 0.114 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.720535e-01 | 0.112 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.732537e-01 | 0.112 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.776217e-01 | 0.109 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.776217e-01 | 0.109 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.801515e-01 | 0.108 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.801515e-01 | 0.108 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.801515e-01 | 0.108 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.801515e-01 | 0.108 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.801515e-01 | 0.108 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.801515e-01 | 0.108 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.801515e-01 | 0.108 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.801515e-01 | 0.108 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.801515e-01 | 0.108 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.801515e-01 | 0.108 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.801515e-01 | 0.108 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.821500e-01 | 0.107 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.825237e-01 | 0.107 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.836046e-01 | 0.106 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.852806e-01 | 0.105 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.852806e-01 | 0.105 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.852806e-01 | 0.105 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.852806e-01 | 0.105 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.855547e-01 | 0.105 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.859953e-01 | 0.105 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.859953e-01 | 0.105 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.859953e-01 | 0.105 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.859953e-01 | 0.105 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.859953e-01 | 0.105 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.898176e-01 | 0.102 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.901612e-01 | 0.102 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.970522e-01 | 0.099 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.970522e-01 | 0.099 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.992518e-01 | 0.097 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.997308e-01 | 0.097 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.017407e-01 | 0.096 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.017407e-01 | 0.096 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.021153e-01 | 0.096 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.046636e-01 | 0.094 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.052905e-01 | 0.094 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.052905e-01 | 0.094 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.052905e-01 | 0.094 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.052905e-01 | 0.094 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.052905e-01 | 0.094 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.052905e-01 | 0.094 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.062336e-01 | 0.094 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.062336e-01 | 0.094 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.062336e-01 | 0.094 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.062336e-01 | 0.094 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.062336e-01 | 0.094 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.062336e-01 | 0.094 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.062336e-01 | 0.094 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.062336e-01 | 0.094 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.062336e-01 | 0.094 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.062336e-01 | 0.094 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.088350e-01 | 0.092 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.098336e-01 | 0.092 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.142099e-01 | 0.089 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.142099e-01 | 0.089 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.161729e-01 | 0.088 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.171274e-01 | 0.088 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.171274e-01 | 0.088 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.171274e-01 | 0.088 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.171835e-01 | 0.088 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.173110e-01 | 0.088 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.181053e-01 | 0.087 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.184365e-01 | 0.087 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.201448e-01 | 0.086 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.207081e-01 | 0.086 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.230211e-01 | 0.085 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.230211e-01 | 0.085 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.230211e-01 | 0.085 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.230211e-01 | 0.085 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.276353e-01 | 0.082 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.292228e-01 | 0.081 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.292228e-01 | 0.081 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.292228e-01 | 0.081 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.292228e-01 | 0.081 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.292228e-01 | 0.081 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.292228e-01 | 0.081 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.292228e-01 | 0.081 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.292228e-01 | 0.081 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.308866e-01 | 0.080 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.314866e-01 | 0.080 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.392868e-01 | 0.076 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.392868e-01 | 0.076 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.392868e-01 | 0.076 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.430233e-01 | 0.074 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.448656e-01 | 0.073 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.475047e-01 | 0.072 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.494857e-01 | 0.071 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.494857e-01 | 0.071 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.494857e-01 | 0.071 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.494857e-01 | 0.071 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.494857e-01 | 0.071 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.494857e-01 | 0.071 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.494857e-01 | 0.071 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.494857e-01 | 0.071 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.494857e-01 | 0.071 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.494857e-01 | 0.071 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.494857e-01 | 0.071 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.541854e-01 | 0.068 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.542066e-01 | 0.068 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.542066e-01 | 0.068 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.542066e-01 | 0.068 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.543454e-01 | 0.068 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.546375e-01 | 0.068 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.555205e-01 | 0.068 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.573123e-01 | 0.067 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.573123e-01 | 0.067 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.602451e-01 | 0.065 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.602451e-01 | 0.065 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.623565e-01 | 0.064 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.643540e-01 | 0.063 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.648044e-01 | 0.063 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.648044e-01 | 0.063 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.665685e-01 | 0.062 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.673454e-01 | 0.062 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.673454e-01 | 0.062 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.673454e-01 | 0.062 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.673454e-01 | 0.062 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.673454e-01 | 0.062 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.673454e-01 | 0.062 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.673454e-01 | 0.062 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.673454e-01 | 0.062 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.673454e-01 | 0.062 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.673454e-01 | 0.062 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.673454e-01 | 0.062 | 0 | 0 |
| Metallothioneins bind metals | R-HSA-5661231 | 8.673454e-01 | 0.062 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.673454e-01 | 0.062 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.673454e-01 | 0.062 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 8.678124e-01 | 0.062 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.678124e-01 | 0.062 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.688752e-01 | 0.061 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.735181e-01 | 0.059 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.735181e-01 | 0.059 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.743393e-01 | 0.058 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.747343e-01 | 0.058 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.747343e-01 | 0.058 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.747343e-01 | 0.058 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.763549e-01 | 0.057 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.773160e-01 | 0.057 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.792885e-01 | 0.056 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.792885e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.792885e-01 | 0.056 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.792885e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.792885e-01 | 0.056 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.796026e-01 | 0.056 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.799013e-01 | 0.056 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.821513e-01 | 0.054 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.821513e-01 | 0.054 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.823573e-01 | 0.054 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.830868e-01 | 0.054 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.830868e-01 | 0.054 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.830868e-01 | 0.054 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.830868e-01 | 0.054 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.830868e-01 | 0.054 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.830868e-01 | 0.054 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.830868e-01 | 0.054 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.830868e-01 | 0.054 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.830868e-01 | 0.054 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.840282e-01 | 0.054 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.875501e-01 | 0.052 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.895418e-01 | 0.051 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.895418e-01 | 0.051 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.895418e-01 | 0.051 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.916152e-01 | 0.050 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.916152e-01 | 0.050 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.916152e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.916152e-01 | 0.050 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.916152e-01 | 0.050 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.969611e-01 | 0.047 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.969611e-01 | 0.047 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.969611e-01 | 0.047 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.969611e-01 | 0.047 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 8.969611e-01 | 0.047 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 8.969611e-01 | 0.047 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 8.969611e-01 | 0.047 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.969611e-01 | 0.047 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.969611e-01 | 0.047 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.969611e-01 | 0.047 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.969611e-01 | 0.047 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.969611e-01 | 0.047 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.969611e-01 | 0.047 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.969611e-01 | 0.047 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.979125e-01 | 0.047 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.003716e-01 | 0.046 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.003716e-01 | 0.046 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.019629e-01 | 0.045 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.019629e-01 | 0.045 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.019629e-01 | 0.045 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.019629e-01 | 0.045 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.019629e-01 | 0.045 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.019629e-01 | 0.045 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.019629e-01 | 0.045 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.019629e-01 | 0.045 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.039620e-01 | 0.044 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.050841e-01 | 0.043 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.068342e-01 | 0.042 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.072413e-01 | 0.042 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.072413e-01 | 0.042 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.082327e-01 | 0.042 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.082327e-01 | 0.042 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.091896e-01 | 0.041 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.091896e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.091896e-01 | 0.041 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.091896e-01 | 0.041 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.091896e-01 | 0.041 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.091896e-01 | 0.041 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.091896e-01 | 0.041 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.091896e-01 | 0.041 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.091896e-01 | 0.041 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.091896e-01 | 0.041 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.091896e-01 | 0.041 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.099800e-01 | 0.041 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.113818e-01 | 0.040 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.113818e-01 | 0.040 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.113818e-01 | 0.040 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.118120e-01 | 0.040 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.118354e-01 | 0.040 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.118455e-01 | 0.040 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.133995e-01 | 0.039 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.136852e-01 | 0.039 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.150907e-01 | 0.039 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.162372e-01 | 0.038 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.199467e-01 | 0.036 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.199675e-01 | 0.036 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.199675e-01 | 0.036 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.199675e-01 | 0.036 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.199675e-01 | 0.036 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.199675e-01 | 0.036 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.199675e-01 | 0.036 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.199675e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.199675e-01 | 0.036 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.199675e-01 | 0.036 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.217850e-01 | 0.035 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.217850e-01 | 0.035 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.219914e-01 | 0.035 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.223303e-01 | 0.035 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.228729e-01 | 0.035 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.240216e-01 | 0.034 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.240216e-01 | 0.034 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.245281e-01 | 0.034 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.272013e-01 | 0.033 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.272013e-01 | 0.033 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.272013e-01 | 0.033 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.277275e-01 | 0.033 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.277275e-01 | 0.033 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.277275e-01 | 0.033 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.277275e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.284297e-01 | 0.032 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.290006e-01 | 0.032 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.290006e-01 | 0.032 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.290006e-01 | 0.032 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.294667e-01 | 0.032 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.294667e-01 | 0.032 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.294667e-01 | 0.032 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.294667e-01 | 0.032 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.294667e-01 | 0.032 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.294667e-01 | 0.032 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.294667e-01 | 0.032 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.294667e-01 | 0.032 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.294667e-01 | 0.032 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.294667e-01 | 0.032 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.294667e-01 | 0.032 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.294667e-01 | 0.032 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.294667e-01 | 0.032 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.294667e-01 | 0.032 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.321939e-01 | 0.030 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.337535e-01 | 0.030 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.347897e-01 | 0.029 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.347897e-01 | 0.029 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.347897e-01 | 0.029 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.351404e-01 | 0.029 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.351404e-01 | 0.029 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.351404e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.353360e-01 | 0.029 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.368810e-01 | 0.028 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.378390e-01 | 0.028 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.378390e-01 | 0.028 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.378390e-01 | 0.028 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.378390e-01 | 0.028 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.378390e-01 | 0.028 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.378390e-01 | 0.028 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.378390e-01 | 0.028 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.378390e-01 | 0.028 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.378390e-01 | 0.028 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.390837e-01 | 0.027 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.395277e-01 | 0.027 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.395277e-01 | 0.027 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.407867e-01 | 0.027 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.411942e-01 | 0.026 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.411942e-01 | 0.026 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.411942e-01 | 0.026 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.411942e-01 | 0.026 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.421265e-01 | 0.026 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.426410e-01 | 0.026 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.438845e-01 | 0.025 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.441690e-01 | 0.025 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.442410e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.452179e-01 | 0.024 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.452179e-01 | 0.024 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.452179e-01 | 0.024 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.452179e-01 | 0.024 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.452179e-01 | 0.024 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.452179e-01 | 0.024 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.452179e-01 | 0.024 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.459743e-01 | 0.024 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.459743e-01 | 0.024 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.464370e-01 | 0.024 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.469976e-01 | 0.024 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.469976e-01 | 0.024 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.473643e-01 | 0.023 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.482193e-01 | 0.023 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.484002e-01 | 0.023 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.484002e-01 | 0.023 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.486252e-01 | 0.023 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.492148e-01 | 0.023 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.498755e-01 | 0.022 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.507366e-01 | 0.022 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.509947e-01 | 0.022 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.517212e-01 | 0.021 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.517212e-01 | 0.021 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.517212e-01 | 0.021 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.517212e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.517212e-01 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.521260e-01 | 0.021 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.522460e-01 | 0.021 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.525803e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.541171e-01 | 0.020 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.554351e-01 | 0.020 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.554351e-01 | 0.020 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.556830e-01 | 0.020 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.561690e-01 | 0.019 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.564227e-01 | 0.019 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.570068e-01 | 0.019 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.570068e-01 | 0.019 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.571401e-01 | 0.019 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.574529e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.574529e-01 | 0.019 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.574529e-01 | 0.019 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.574529e-01 | 0.019 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.578326e-01 | 0.019 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.591082e-01 | 0.018 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.591450e-01 | 0.018 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.591450e-01 | 0.018 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.603668e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.604018e-01 | 0.018 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.613057e-01 | 0.017 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.613057e-01 | 0.017 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.614867e-01 | 0.017 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.622891e-01 | 0.017 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.625044e-01 | 0.017 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.625044e-01 | 0.017 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.625044e-01 | 0.017 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.625044e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.625044e-01 | 0.017 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.627746e-01 | 0.016 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.627746e-01 | 0.016 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.627746e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.648760e-01 | 0.016 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.651902e-01 | 0.015 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.651902e-01 | 0.015 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.651902e-01 | 0.015 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.661299e-01 | 0.015 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.661299e-01 | 0.015 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.661299e-01 | 0.015 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.661299e-01 | 0.015 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.661299e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.669360e-01 | 0.015 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.669564e-01 | 0.015 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.669564e-01 | 0.015 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.679292e-01 | 0.014 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.686981e-01 | 0.014 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.686981e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.691740e-01 | 0.014 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.708800e-01 | 0.013 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.708800e-01 | 0.013 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.708800e-01 | 0.013 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.708800e-01 | 0.013 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 9.708800e-01 | 0.013 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.708800e-01 | 0.013 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.709955e-01 | 0.013 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.717622e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.717622e-01 | 0.012 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.718640e-01 | 0.012 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.718640e-01 | 0.012 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.718640e-01 | 0.012 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.724442e-01 | 0.012 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.729949e-01 | 0.012 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.743379e-01 | 0.011 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.743379e-01 | 0.011 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.743379e-01 | 0.011 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.743379e-01 | 0.011 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.743379e-01 | 0.011 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.743379e-01 | 0.011 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.743379e-01 | 0.011 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.744116e-01 | 0.011 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.745634e-01 | 0.011 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.745634e-01 | 0.011 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.745634e-01 | 0.011 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.747197e-01 | 0.011 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.747197e-01 | 0.011 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.747197e-01 | 0.011 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.747197e-01 | 0.011 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.747197e-01 | 0.011 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.772941e-01 | 0.010 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.772941e-01 | 0.010 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.773854e-01 | 0.010 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.773854e-01 | 0.010 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.783574e-01 | 0.010 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.790328e-01 | 0.009 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.796138e-01 | 0.009 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.800712e-01 | 0.009 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.800712e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.800712e-01 | 0.009 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.800712e-01 | 0.009 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.800712e-01 | 0.009 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.800712e-01 | 0.009 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.807063e-01 | 0.008 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.810566e-01 | 0.008 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.814695e-01 | 0.008 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.817029e-01 | 0.008 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.818634e-01 | 0.008 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.824381e-01 | 0.008 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.824381e-01 | 0.008 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.824381e-01 | 0.008 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.826583e-01 | 0.008 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.826583e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.835202e-01 | 0.007 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.835835e-01 | 0.007 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.843593e-01 | 0.007 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.845240e-01 | 0.007 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.845240e-01 | 0.007 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.845240e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.845240e-01 | 0.007 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.845240e-01 | 0.007 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.847809e-01 | 0.007 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.848673e-01 | 0.007 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.852757e-01 | 0.006 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.852757e-01 | 0.006 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.852757e-01 | 0.006 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.852757e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.852757e-01 | 0.006 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.863623e-01 | 0.006 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.879823e-01 | 0.005 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.879823e-01 | 0.005 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.881658e-01 | 0.005 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.883123e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.883748e-01 | 0.005 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.888875e-01 | 0.005 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.893954e-01 | 0.005 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.894260e-01 | 0.005 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.894774e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.902951e-01 | 0.004 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.904999e-01 | 0.004 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.906681e-01 | 0.004 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.906681e-01 | 0.004 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.906681e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.910116e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.913882e-01 | 0.004 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.917768e-01 | 0.004 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.922132e-01 | 0.003 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.922132e-01 | 0.003 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.923821e-01 | 0.003 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.923821e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.927539e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.929355e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.931811e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.936149e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.936149e-01 | 0.003 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.936149e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.938978e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.942295e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.942904e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.943614e-01 | 0.002 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.943736e-01 | 0.002 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.943736e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.943736e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.943736e-01 | 0.002 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.943736e-01 | 0.002 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.950423e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.950423e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.950423e-01 | 0.002 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.951167e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.954238e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.955622e-01 | 0.002 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.956315e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.956315e-01 | 0.002 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.956330e-01 | 0.002 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.956330e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.956330e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.960957e-01 | 0.002 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.961507e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.961507e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.961507e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.961507e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.966082e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.966082e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.967534e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.972042e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.972042e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.972567e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.972899e-01 | 0.001 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.973666e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.973666e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.973666e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.974590e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.975367e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.975508e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.976797e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.979454e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.979551e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.980147e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.981045e-01 | 0.001 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.981585e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.981986e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.981986e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.982275e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.983540e-01 | 0.001 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.984059e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.984128e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.984178e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.984178e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.984718e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.984718e-01 | 0.001 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.986015e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.986015e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.986015e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.986198e-01 | 0.001 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.987678e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.987678e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.987678e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.987918e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.988659e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.988759e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.989352e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.990435e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.990435e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.991057e-01 | 0.000 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.991572e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.993458e-01 | 0.000 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.994236e-01 | 0.000 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.994236e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.994236e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.994350e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994829e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.994965e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.994965e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.994965e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.995425e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.995513e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.995644e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996002e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.996058e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.996527e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.996941e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997743e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997760e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.997908e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997908e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998157e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998279e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998420e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998527e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998740e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998890e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998994e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999216e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999241e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999241e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999292e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999331e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999510e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999514e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999641e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999692e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999728e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999812e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999812e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999857e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999871e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.999900e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999912e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999920e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999941e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999945e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999953e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999987e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999990e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999994e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999995e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999996e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999996e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-15 | 14.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.718448e-14 | 13.326 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.128298e-13 | 12.672 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.567413e-12 | 11.805 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.297229e-12 | 11.367 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.153766e-12 | 11.288 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.262613e-12 | 11.083 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.146727e-11 | 10.941 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.340517e-11 | 10.873 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.259405e-10 | 9.900 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.494531e-10 | 9.603 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.534975e-10 | 9.452 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.353372e-10 | 9.361 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.794900e-10 | 9.319 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.766481e-10 | 9.239 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.766481e-10 | 9.239 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.038546e-09 | 8.984 | 1 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.146207e-09 | 8.941 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.274003e-09 | 8.895 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.744832e-09 | 8.758 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.193775e-09 | 8.659 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.193775e-09 | 8.659 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.155388e-09 | 8.666 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.965066e-09 | 8.528 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.008038e-09 | 8.522 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.400453e-09 | 8.468 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.320522e-09 | 8.364 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.911349e-09 | 8.160 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.814943e-09 | 8.167 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.583034e-09 | 8.120 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.921976e-09 | 8.101 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.058466e-09 | 8.094 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.609169e-09 | 8.065 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.028414e-08 | 7.988 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.056459e-08 | 7.976 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.228058e-08 | 7.911 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.265027e-08 | 7.898 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.355697e-08 | 7.868 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.603328e-08 | 7.795 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.603328e-08 | 7.795 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.809151e-08 | 7.743 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.176733e-08 | 7.662 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.176733e-08 | 7.662 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.176733e-08 | 7.662 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.176733e-08 | 7.662 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.470709e-08 | 7.607 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.272152e-08 | 7.485 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.219046e-08 | 7.492 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.450144e-08 | 7.462 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.179279e-08 | 7.379 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.431869e-08 | 7.353 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.760430e-08 | 7.322 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.974245e-08 | 7.303 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.103051e-08 | 7.214 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.597674e-08 | 7.181 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.676020e-08 | 7.115 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.068328e-07 | 6.971 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.187960e-07 | 6.925 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.356604e-07 | 6.868 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.409472e-07 | 6.851 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.526985e-07 | 6.816 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.855588e-07 | 6.732 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.958679e-07 | 6.708 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.958679e-07 | 6.708 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.474196e-07 | 6.607 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.422911e-07 | 6.616 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.579569e-07 | 6.588 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.579569e-07 | 6.588 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.651618e-07 | 6.576 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.878318e-07 | 6.541 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.310794e-07 | 6.480 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.310794e-07 | 6.480 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.292911e-07 | 6.482 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.351519e-07 | 6.475 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.360182e-07 | 6.474 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.014103e-07 | 6.396 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.242490e-07 | 6.372 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.830277e-07 | 6.316 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.880312e-07 | 6.312 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.571431e-07 | 6.254 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.309406e-07 | 6.275 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.703093e-07 | 6.244 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.935275e-07 | 6.227 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.083651e-07 | 6.216 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.659559e-07 | 6.177 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.328661e-07 | 6.199 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.703194e-07 | 6.174 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.522196e-07 | 6.069 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.298688e-07 | 6.032 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.748337e-07 | 6.011 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.271085e-07 | 6.033 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.615587e-07 | 6.017 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.129988e-06 | 5.947 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.320572e-06 | 5.879 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.283660e-06 | 5.892 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.322768e-06 | 5.879 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.283660e-06 | 5.892 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.428646e-06 | 5.845 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.572955e-06 | 5.803 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.546972e-06 | 5.811 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.566381e-06 | 5.805 | 1 | 1 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.649743e-06 | 5.783 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.973199e-06 | 5.705 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.157717e-06 | 5.666 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.391126e-06 | 5.621 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.630923e-06 | 5.580 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.630923e-06 | 5.580 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.790632e-06 | 5.554 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.674156e-06 | 5.573 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.905136e-06 | 5.537 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.964355e-06 | 5.528 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.227873e-06 | 5.491 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.233233e-06 | 5.490 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.615365e-06 | 5.442 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.792011e-06 | 5.421 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.836821e-06 | 5.416 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.123228e-06 | 5.385 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.296989e-06 | 5.367 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.557558e-06 | 5.341 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.574780e-06 | 5.340 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.944430e-06 | 5.306 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.060535e-06 | 5.296 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.456630e-06 | 5.263 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.813948e-06 | 5.236 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.978283e-06 | 5.223 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.640893e-06 | 5.178 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.910126e-06 | 5.161 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.001182e-06 | 5.155 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.360912e-06 | 5.133 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.419700e-06 | 5.130 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.751113e-06 | 5.111 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.758964e-06 | 5.110 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.807291e-06 | 5.107 | 1 | 1 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.862111e-06 | 5.052 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.657488e-06 | 5.015 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.963448e-06 | 5.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.013306e-05 | 4.994 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.034715e-05 | 4.985 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.035544e-05 | 4.985 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.134671e-05 | 4.945 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.179913e-05 | 4.928 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.321050e-05 | 4.879 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.310882e-05 | 4.882 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.257209e-05 | 4.901 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.363377e-05 | 4.865 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.380823e-05 | 4.860 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.411134e-05 | 4.850 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.489456e-05 | 4.827 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.500087e-05 | 4.824 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.696714e-05 | 4.770 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.742529e-05 | 4.759 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.791456e-05 | 4.747 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.023940e-05 | 4.694 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.023940e-05 | 4.694 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.107457e-05 | 4.676 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.169551e-05 | 4.664 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.436600e-05 | 4.613 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.408827e-05 | 4.618 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.494242e-05 | 4.603 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.494242e-05 | 4.603 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.532707e-05 | 4.596 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.561756e-05 | 4.591 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.690114e-05 | 4.570 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.904198e-05 | 4.537 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.904198e-05 | 4.537 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.983281e-05 | 4.525 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.058793e-05 | 4.514 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.075062e-05 | 4.512 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.106242e-05 | 4.508 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.171585e-05 | 4.499 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.171585e-05 | 4.499 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.306350e-05 | 4.481 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.646847e-05 | 4.438 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.085611e-05 | 4.389 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.850867e-05 | 4.414 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.848418e-05 | 4.415 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.792391e-05 | 4.421 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.275572e-05 | 4.369 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.607852e-05 | 4.337 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.607852e-05 | 4.337 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.804879e-05 | 4.318 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.804879e-05 | 4.318 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.025601e-05 | 4.299 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.253322e-05 | 4.280 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.377095e-05 | 4.269 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.987139e-05 | 4.223 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.505058e-05 | 4.187 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.505058e-05 | 4.187 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.659588e-05 | 4.177 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.889312e-05 | 4.162 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.049775e-05 | 4.152 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.969080e-05 | 4.099 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.969080e-05 | 4.099 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.702331e-05 | 4.113 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.466874e-05 | 4.127 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.969080e-05 | 4.099 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.986691e-05 | 4.098 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.133858e-05 | 4.090 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.313771e-05 | 4.080 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.343408e-05 | 4.079 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.461191e-05 | 4.073 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.726538e-05 | 4.059 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.780541e-05 | 4.056 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.176846e-05 | 4.037 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.323521e-05 | 4.030 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.338265e-05 | 4.030 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.599628e-05 | 4.018 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.038022e-04 | 3.984 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.063053e-04 | 3.973 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.064880e-04 | 3.973 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.099588e-04 | 3.959 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.202856e-04 | 3.920 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.219421e-04 | 3.914 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.281702e-04 | 3.892 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.320696e-04 | 3.879 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.342766e-04 | 3.872 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.347640e-04 | 3.870 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.347640e-04 | 3.870 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.546258e-04 | 3.811 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.522947e-04 | 3.817 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.519530e-04 | 3.818 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.478597e-04 | 3.830 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.645200e-04 | 3.784 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.647796e-04 | 3.783 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.697549e-04 | 3.770 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.697549e-04 | 3.770 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.747305e-04 | 3.758 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.794648e-04 | 3.746 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.795682e-04 | 3.746 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.921364e-04 | 3.716 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.977271e-04 | 3.704 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.033603e-04 | 3.692 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.105811e-04 | 3.677 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.120826e-04 | 3.673 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.252080e-04 | 3.647 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.409347e-04 | 3.618 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.487862e-04 | 3.604 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.596084e-04 | 3.586 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.596084e-04 | 3.586 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.621207e-04 | 3.581 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.623772e-04 | 3.581 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.631756e-04 | 3.580 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.702665e-04 | 3.568 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.819918e-04 | 3.550 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.819918e-04 | 3.550 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.890070e-04 | 3.539 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.192871e-04 | 3.496 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.386860e-04 | 3.470 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.386860e-04 | 3.470 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.046675e-04 | 3.516 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.329123e-04 | 3.478 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.403587e-04 | 3.468 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.321567e-04 | 3.479 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.184392e-04 | 3.497 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.403587e-04 | 3.468 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.373893e-04 | 3.472 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.106537e-04 | 3.508 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.105785e-04 | 3.508 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.403587e-04 | 3.468 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.931503e-04 | 3.405 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.183594e-04 | 3.378 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.211060e-04 | 3.376 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.844850e-04 | 3.315 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.885422e-04 | 3.311 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.921743e-04 | 3.308 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.921743e-04 | 3.308 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.038712e-04 | 3.298 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.056556e-04 | 3.296 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.154292e-04 | 3.288 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.197237e-04 | 3.284 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.197237e-04 | 3.284 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.376357e-04 | 3.270 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.499606e-04 | 3.260 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.804836e-04 | 3.236 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.026655e-04 | 3.220 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.026655e-04 | 3.220 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.232975e-04 | 3.205 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.311091e-04 | 3.200 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.311091e-04 | 3.200 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.435199e-04 | 3.191 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.676298e-04 | 3.175 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.683838e-04 | 3.175 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.683838e-04 | 3.175 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.899775e-04 | 3.161 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.918043e-04 | 3.160 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.918043e-04 | 3.160 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.948609e-04 | 3.158 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.301001e-04 | 3.137 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.301001e-04 | 3.137 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.461625e-04 | 3.127 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.863647e-04 | 3.104 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.074946e-04 | 3.093 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.824509e-04 | 3.054 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.529472e-04 | 3.021 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.582782e-04 | 3.066 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.500888e-04 | 3.071 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.824509e-04 | 3.054 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.012060e-03 | 2.995 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.326347e-04 | 3.030 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.485823e-04 | 3.071 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.649254e-04 | 3.063 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.876961e-04 | 3.005 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.070142e-03 | 2.971 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.074691e-03 | 2.969 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.079612e-03 | 2.967 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.089536e-03 | 2.963 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.115993e-03 | 2.952 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.116525e-03 | 2.952 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.127968e-03 | 2.948 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.127968e-03 | 2.948 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.129625e-03 | 2.947 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.129625e-03 | 2.947 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.129625e-03 | 2.947 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.129625e-03 | 2.947 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.230659e-03 | 2.910 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.289280e-03 | 2.890 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.289280e-03 | 2.890 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.289280e-03 | 2.890 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.308477e-03 | 2.883 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.339898e-03 | 2.873 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.420399e-03 | 2.848 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.461577e-03 | 2.835 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.469420e-03 | 2.833 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.500255e-03 | 2.824 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.500255e-03 | 2.824 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.505367e-03 | 2.822 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.523021e-03 | 2.817 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.575055e-03 | 2.803 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.596197e-03 | 2.797 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.602446e-03 | 2.795 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.616191e-03 | 2.792 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.616191e-03 | 2.792 | 0 | 0 |
| Translation | R-HSA-72766 | 1.640904e-03 | 2.785 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.716935e-03 | 2.765 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.944457e-03 | 2.711 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.948528e-03 | 2.710 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.965813e-03 | 2.706 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.970074e-03 | 2.706 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.182693e-03 | 2.661 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.228962e-03 | 2.652 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.251276e-03 | 2.648 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.251276e-03 | 2.648 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.285818e-03 | 2.641 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.291371e-03 | 2.640 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.291371e-03 | 2.640 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.301796e-03 | 2.638 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.478112e-03 | 2.606 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.478112e-03 | 2.606 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.514464e-03 | 2.600 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.622432e-03 | 2.581 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.692525e-03 | 2.570 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.694853e-03 | 2.569 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.864637e-03 | 2.543 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.886022e-03 | 2.540 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.611040e-03 | 2.442 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.611040e-03 | 2.442 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.988279e-03 | 2.525 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.390976e-03 | 2.470 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.971983e-03 | 2.527 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.978992e-03 | 2.526 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.103149e-03 | 2.508 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.344896e-03 | 2.476 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.642301e-03 | 2.439 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.642301e-03 | 2.439 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.661538e-03 | 2.436 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.661538e-03 | 2.436 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.730006e-03 | 2.428 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.730006e-03 | 2.428 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.000783e-03 | 2.398 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.071381e-03 | 2.390 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.427797e-03 | 2.354 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.442084e-03 | 2.352 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.442084e-03 | 2.352 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.450654e-03 | 2.352 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.495635e-03 | 2.347 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.678521e-03 | 2.330 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.678521e-03 | 2.330 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.678521e-03 | 2.330 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.957416e-03 | 2.305 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.957416e-03 | 2.305 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.957416e-03 | 2.305 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.957416e-03 | 2.305 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.957416e-03 | 2.305 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.985357e-03 | 2.302 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.099328e-03 | 2.292 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.106673e-03 | 2.292 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.109299e-03 | 2.292 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.210195e-03 | 2.283 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.435046e-03 | 2.265 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.532842e-03 | 2.257 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.590980e-03 | 2.253 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.590980e-03 | 2.253 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.733601e-03 | 2.242 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.747106e-03 | 2.241 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.747106e-03 | 2.241 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.918175e-03 | 2.228 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.918175e-03 | 2.228 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.918175e-03 | 2.228 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.918175e-03 | 2.228 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.918175e-03 | 2.228 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.918175e-03 | 2.228 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.941252e-03 | 2.226 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.947239e-03 | 2.226 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.043402e-03 | 2.219 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.312168e-03 | 2.200 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.379241e-03 | 2.195 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.016488e-03 | 2.154 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.072381e-03 | 2.150 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.072381e-03 | 2.150 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.191465e-03 | 2.143 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.191465e-03 | 2.143 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.325328e-03 | 2.135 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.363672e-03 | 2.133 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.398535e-03 | 2.131 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.593233e-03 | 2.120 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.593233e-03 | 2.120 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.621163e-03 | 2.118 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.719785e-03 | 2.112 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.719785e-03 | 2.112 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.745456e-03 | 2.111 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.934973e-03 | 2.100 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.044560e-02 | 1.981 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.044560e-02 | 1.981 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 8.170355e-03 | 2.088 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.234627e-03 | 2.084 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.896936e-03 | 2.004 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.061437e-02 | 1.974 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.477182e-03 | 2.023 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.557361e-03 | 2.068 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.430673e-03 | 2.074 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.626264e-03 | 2.017 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.557361e-03 | 2.068 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 8.170355e-03 | 2.088 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.666675e-03 | 2.015 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.833436e-03 | 2.007 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.364948e-03 | 2.078 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.531093e-03 | 2.021 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.477182e-03 | 2.023 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.845773e-03 | 2.007 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.774764e-03 | 2.057 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.057882e-02 | 1.976 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.490155e-03 | 2.023 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.477182e-03 | 2.023 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.531686e-03 | 2.069 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.447957e-03 | 2.025 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.871034e-03 | 2.052 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 8.234627e-03 | 2.084 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.050309e-02 | 1.979 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.068635e-02 | 1.971 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.095116e-02 | 1.961 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.119432e-02 | 1.951 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.138073e-02 | 1.944 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.148064e-02 | 1.940 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.148064e-02 | 1.940 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.149257e-02 | 1.940 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.149257e-02 | 1.940 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.163874e-02 | 1.934 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.163874e-02 | 1.934 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.163874e-02 | 1.934 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.168043e-02 | 1.933 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.168043e-02 | 1.933 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.187705e-02 | 1.925 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.230800e-02 | 1.910 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.230800e-02 | 1.910 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.241431e-02 | 1.906 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.241431e-02 | 1.906 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.246619e-02 | 1.904 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.272924e-02 | 1.895 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.272924e-02 | 1.895 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.272924e-02 | 1.895 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.279112e-02 | 1.893 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.279112e-02 | 1.893 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.279112e-02 | 1.893 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.279112e-02 | 1.893 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.320763e-02 | 1.879 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.325119e-02 | 1.878 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.334924e-02 | 1.875 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.335722e-02 | 1.874 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.402476e-02 | 1.853 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.422177e-02 | 1.847 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.435260e-02 | 1.843 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.461850e-02 | 1.835 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.512622e-02 | 1.820 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.544226e-02 | 1.811 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.544226e-02 | 1.811 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.554072e-02 | 1.809 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.589149e-02 | 1.799 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.589149e-02 | 1.799 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.589149e-02 | 1.799 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.633371e-02 | 1.787 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.633371e-02 | 1.787 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.714327e-02 | 1.766 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.724882e-02 | 1.763 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.724882e-02 | 1.763 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.743405e-02 | 1.759 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.743405e-02 | 1.759 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.796789e-02 | 1.746 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.801680e-02 | 1.744 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.869639e-02 | 1.728 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.869639e-02 | 1.728 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.880966e-02 | 1.726 | 1 | 1 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.908526e-02 | 1.719 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.958778e-02 | 1.708 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.033258e-02 | 1.692 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.063386e-02 | 1.685 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.063386e-02 | 1.685 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.083453e-02 | 1.681 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.102194e-02 | 1.677 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.102194e-02 | 1.677 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.102194e-02 | 1.677 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.107014e-02 | 1.676 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.121914e-02 | 1.673 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.121914e-02 | 1.673 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.178210e-02 | 1.662 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.212177e-02 | 1.655 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.212177e-02 | 1.655 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.212177e-02 | 1.655 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.212177e-02 | 1.655 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.212177e-02 | 1.655 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.215525e-02 | 1.655 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.351947e-02 | 1.629 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.396029e-02 | 1.621 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.439086e-02 | 1.613 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.496310e-02 | 1.603 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.631158e-02 | 1.580 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.632925e-02 | 1.580 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.723933e-02 | 1.565 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.723933e-02 | 1.565 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.741050e-02 | 1.562 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.741050e-02 | 1.562 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.779729e-02 | 1.556 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.779729e-02 | 1.556 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.802289e-02 | 1.552 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.802289e-02 | 1.552 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.846169e-02 | 1.546 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.000461e-02 | 1.523 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.000461e-02 | 1.523 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.000461e-02 | 1.523 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.541646e-02 | 1.451 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.444999e-02 | 1.463 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.302670e-02 | 1.481 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.302670e-02 | 1.481 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.887351e-02 | 1.410 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.708084e-02 | 1.431 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.708084e-02 | 1.431 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.534566e-02 | 1.452 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.741303e-02 | 1.427 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.929557e-02 | 1.533 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.940985e-02 | 1.532 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.139982e-02 | 1.503 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.139982e-02 | 1.503 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.534566e-02 | 1.452 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.696073e-02 | 1.432 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.075991e-02 | 1.512 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.444999e-02 | 1.463 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.000461e-02 | 1.523 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.444999e-02 | 1.463 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.444999e-02 | 1.463 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.444999e-02 | 1.463 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.444999e-02 | 1.463 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.887351e-02 | 1.410 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.273868e-02 | 1.369 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.968232e-02 | 1.528 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.302670e-02 | 1.481 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.435020e-02 | 1.464 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.018400e-02 | 1.520 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.541646e-02 | 1.451 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.541646e-02 | 1.451 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.985871e-02 | 1.399 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.338973e-02 | 1.476 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.338973e-02 | 1.476 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.566678e-02 | 1.448 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.896852e-02 | 1.538 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.273868e-02 | 1.369 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.708084e-02 | 1.431 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.215836e-02 | 1.375 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.215836e-02 | 1.375 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.929557e-02 | 1.533 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.018400e-02 | 1.520 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.215836e-02 | 1.375 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.968232e-02 | 1.528 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.882243e-02 | 1.411 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.741303e-02 | 1.427 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.929557e-02 | 1.533 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.302670e-02 | 1.481 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.444999e-02 | 1.463 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.002237e-02 | 1.398 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.660911e-02 | 1.436 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.541646e-02 | 1.451 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.392106e-02 | 1.357 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.392106e-02 | 1.357 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.392106e-02 | 1.357 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.392106e-02 | 1.357 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.398929e-02 | 1.357 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.398929e-02 | 1.357 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.398929e-02 | 1.357 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.410834e-02 | 1.355 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.410834e-02 | 1.355 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.410834e-02 | 1.355 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.411382e-02 | 1.355 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 4.442236e-02 | 1.352 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.442236e-02 | 1.352 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.442236e-02 | 1.352 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.475216e-02 | 1.349 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.475216e-02 | 1.349 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.475216e-02 | 1.349 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.528875e-02 | 1.344 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.610273e-02 | 1.336 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.610273e-02 | 1.336 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.610273e-02 | 1.336 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.610273e-02 | 1.336 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.610273e-02 | 1.336 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.610273e-02 | 1.336 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.630399e-02 | 1.334 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.768378e-02 | 1.322 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.768378e-02 | 1.322 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.768378e-02 | 1.322 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.768378e-02 | 1.322 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.807831e-02 | 1.318 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.855364e-02 | 1.314 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.003693e-02 | 1.301 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.003693e-02 | 1.301 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.037456e-02 | 1.298 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.037456e-02 | 1.298 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.212753e-02 | 1.283 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.212753e-02 | 1.283 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.212753e-02 | 1.283 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.225502e-02 | 1.282 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.249969e-02 | 1.280 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.346552e-02 | 1.272 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.346552e-02 | 1.272 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.572249e-02 | 1.254 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.572249e-02 | 1.254 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.629257e-02 | 1.250 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.718874e-02 | 1.243 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.735598e-02 | 1.241 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.808336e-02 | 1.236 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.838704e-02 | 1.234 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.838704e-02 | 1.234 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.838704e-02 | 1.234 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.962014e-02 | 1.225 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.012268e-02 | 1.221 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.065478e-02 | 1.217 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.065478e-02 | 1.217 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.065478e-02 | 1.217 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.065478e-02 | 1.217 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.087669e-02 | 1.216 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.179910e-02 | 1.209 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.181675e-02 | 1.209 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.181675e-02 | 1.209 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.248133e-02 | 1.204 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.262446e-02 | 1.203 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.262446e-02 | 1.203 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.262446e-02 | 1.203 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.262446e-02 | 1.203 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.262446e-02 | 1.203 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.262446e-02 | 1.203 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.262446e-02 | 1.203 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.347304e-02 | 1.197 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.455992e-02 | 1.190 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.552249e-02 | 1.184 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.790356e-02 | 1.168 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.832606e-02 | 1.165 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.873709e-02 | 1.163 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.873709e-02 | 1.163 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.874867e-02 | 1.163 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.879130e-02 | 1.162 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.000119e-02 | 1.155 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.090701e-02 | 1.149 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.223934e-02 | 1.141 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.233975e-02 | 1.141 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.233975e-02 | 1.141 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.249400e-02 | 1.140 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.249400e-02 | 1.140 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.328851e-02 | 1.135 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 7.353219e-02 | 1.134 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 7.353219e-02 | 1.134 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 7.353219e-02 | 1.134 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.422376e-02 | 1.129 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.422376e-02 | 1.129 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.422376e-02 | 1.129 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.422376e-02 | 1.129 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.427627e-02 | 1.129 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.446493e-02 | 1.128 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.522401e-02 | 1.124 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.525508e-02 | 1.123 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.525508e-02 | 1.123 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.693743e-02 | 1.114 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.795233e-02 | 1.108 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.795233e-02 | 1.108 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.961016e-02 | 1.099 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.981642e-02 | 1.098 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.103231e-02 | 1.091 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.132335e-02 | 1.090 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.208514e-02 | 1.086 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.236115e-02 | 1.084 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.236115e-02 | 1.084 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.236115e-02 | 1.084 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.260678e-02 | 1.083 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.303687e-02 | 1.081 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.344847e-02 | 1.079 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.363611e-02 | 1.078 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.588993e-02 | 1.066 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.690694e-02 | 1.061 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.690694e-02 | 1.061 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.690694e-02 | 1.061 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.690694e-02 | 1.061 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.690694e-02 | 1.061 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.760432e-02 | 1.057 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.760432e-02 | 1.057 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.778765e-02 | 1.057 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.778913e-02 | 1.057 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.778913e-02 | 1.057 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.778913e-02 | 1.057 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.889648e-02 | 1.051 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.975507e-02 | 1.047 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.005844e-02 | 1.045 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.005844e-02 | 1.045 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.007191e-02 | 1.045 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.056961e-02 | 1.043 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.074225e-02 | 1.042 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.074225e-02 | 1.042 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.193101e-02 | 1.037 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.193101e-02 | 1.037 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.049291e-01 | 0.979 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.049291e-01 | 0.979 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.049291e-01 | 0.979 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.049291e-01 | 0.979 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.070550e-01 | 0.970 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.070550e-01 | 0.970 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.070550e-01 | 0.970 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.437452e-01 | 0.842 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.437452e-01 | 0.842 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.437452e-01 | 0.842 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.437452e-01 | 0.842 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.012431e-01 | 0.995 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.012431e-01 | 0.995 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.012431e-01 | 0.995 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.825699e-01 | 0.739 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.825699e-01 | 0.739 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.246747e-01 | 0.904 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.044053e-01 | 0.981 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.044053e-01 | 0.981 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.044053e-01 | 0.981 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.044053e-01 | 0.981 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.225480e-01 | 0.912 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.225480e-01 | 0.912 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.225480e-01 | 0.912 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.225480e-01 | 0.912 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.764486e-01 | 0.753 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.006438e-01 | 0.997 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.006438e-01 | 0.997 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.456164e-02 | 1.024 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.624171e-01 | 0.789 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.624171e-01 | 0.789 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.068962e-01 | 0.971 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.068962e-01 | 0.971 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.829517e-02 | 1.007 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.200163e-01 | 0.921 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.477232e-01 | 0.831 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.477232e-01 | 0.831 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.839001e-01 | 0.735 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.839001e-01 | 0.735 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.094595e-01 | 0.961 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.651802e-01 | 0.782 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.651802e-01 | 0.782 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.637640e-01 | 0.786 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.637640e-01 | 0.786 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.467307e-01 | 0.833 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.436245e-01 | 0.843 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.558986e-01 | 0.807 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.558986e-01 | 0.807 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.686514e-01 | 0.773 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.625585e-01 | 0.789 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.444627e-01 | 0.840 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.788016e-01 | 0.748 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.065255e-01 | 0.973 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.357249e-02 | 1.029 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.072018e-01 | 0.970 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.968464e-02 | 1.001 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.200163e-01 | 0.921 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.960646e-02 | 1.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.745716e-01 | 0.758 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.314662e-01 | 0.881 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.467307e-01 | 0.833 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.200163e-01 | 0.921 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.836845e-01 | 0.736 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.338919e-01 | 0.873 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.338919e-01 | 0.873 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.624171e-01 | 0.789 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.302872e-01 | 0.885 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.834068e-01 | 0.737 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.825699e-01 | 0.739 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.744910e-01 | 0.758 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.498364e-01 | 0.824 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.113744e-01 | 0.953 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.225480e-01 | 0.912 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.829517e-02 | 1.007 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.338919e-01 | 0.873 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.212669e-01 | 0.916 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.467307e-01 | 0.833 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.246747e-01 | 0.904 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.044053e-01 | 0.981 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.205913e-01 | 0.919 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.311133e-01 | 0.882 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.671983e-01 | 0.777 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.437452e-01 | 0.842 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.651802e-01 | 0.782 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.960646e-02 | 1.002 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.397805e-01 | 0.855 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.256886e-01 | 0.901 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.221360e-01 | 0.913 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.449550e-01 | 0.839 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.546317e-01 | 0.811 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.290462e-01 | 0.889 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.619438e-01 | 0.791 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.619438e-01 | 0.791 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.212669e-01 | 0.916 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.419247e-01 | 0.848 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 1.311060e-01 | 0.882 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.181840e-01 | 0.927 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.625585e-01 | 0.789 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.397805e-01 | 0.855 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.825699e-01 | 0.739 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.419247e-01 | 0.848 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.829517e-02 | 1.007 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.744910e-01 | 0.758 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.474810e-01 | 0.831 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.260666e-01 | 0.899 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.467307e-01 | 0.833 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.049244e-01 | 0.979 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.437452e-01 | 0.842 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.825699e-01 | 0.739 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.498364e-01 | 0.824 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.225480e-01 | 0.912 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.311060e-01 | 0.882 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.960646e-02 | 1.002 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.744910e-01 | 0.758 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.503719e-01 | 0.823 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.488110e-02 | 1.023 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.050913e-01 | 0.978 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.050913e-01 | 0.978 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.050913e-01 | 0.978 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.225480e-01 | 0.912 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.355190e-01 | 0.868 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.706844e-01 | 0.768 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.328185e-01 | 0.877 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.556954e-01 | 0.808 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.467307e-01 | 0.833 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.744910e-01 | 0.758 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.419247e-01 | 0.848 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.839001e-01 | 0.735 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.178806e-01 | 0.929 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.070550e-01 | 0.970 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.012431e-01 | 0.995 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.456164e-02 | 1.024 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.834068e-01 | 0.737 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.121796e-01 | 0.950 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.477232e-01 | 0.831 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.226803e-01 | 0.911 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.100810e-01 | 0.958 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.624171e-01 | 0.789 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.132863e-01 | 0.946 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.735720e-01 | 0.761 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.558986e-01 | 0.807 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.184892e-01 | 0.926 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.825699e-01 | 0.739 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.044053e-01 | 0.981 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.044053e-01 | 0.981 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.044053e-01 | 0.981 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.858149e-02 | 1.006 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.817974e-01 | 0.740 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.311060e-01 | 0.882 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.436245e-01 | 0.843 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.651802e-01 | 0.782 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.187658e-01 | 0.925 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.825699e-01 | 0.739 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.839001e-01 | 0.735 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.834068e-01 | 0.737 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.764486e-01 | 0.753 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.809895e-01 | 0.742 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.044053e-01 | 0.981 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.477232e-01 | 0.831 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.044053e-01 | 0.981 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.624171e-01 | 0.789 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.624171e-01 | 0.789 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.477232e-01 | 0.831 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.839001e-01 | 0.735 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.311060e-01 | 0.882 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.419247e-01 | 0.848 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.850058e-01 | 0.733 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.850058e-01 | 0.733 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.852288e-01 | 0.732 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.864323e-01 | 0.729 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.944432e-01 | 0.711 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.955014e-01 | 0.709 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.956958e-01 | 0.708 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.961787e-01 | 0.707 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.961787e-01 | 0.707 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.961787e-01 | 0.707 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.961787e-01 | 0.707 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 1.988536e-01 | 0.701 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.988536e-01 | 0.701 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 1.988536e-01 | 0.701 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.988536e-01 | 0.701 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.988536e-01 | 0.701 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.988536e-01 | 0.701 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.988536e-01 | 0.701 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.988536e-01 | 0.701 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.988536e-01 | 0.701 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.988536e-01 | 0.701 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.988536e-01 | 0.701 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.025590e-01 | 0.693 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.042357e-01 | 0.690 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.042357e-01 | 0.690 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.062441e-01 | 0.686 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.062441e-01 | 0.686 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.062441e-01 | 0.686 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.103228e-01 | 0.677 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.149161e-01 | 0.668 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.217216e-01 | 0.654 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.218690e-01 | 0.654 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.218690e-01 | 0.654 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.218690e-01 | 0.654 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.226778e-01 | 0.652 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.226778e-01 | 0.652 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 2.226778e-01 | 0.652 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 2.226778e-01 | 0.652 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.226778e-01 | 0.652 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 2.226778e-01 | 0.652 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.239726e-01 | 0.650 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.244851e-01 | 0.649 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.263537e-01 | 0.645 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.275687e-01 | 0.643 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.289770e-01 | 0.640 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.293181e-01 | 0.640 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.293181e-01 | 0.640 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.293181e-01 | 0.640 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.293181e-01 | 0.640 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.293181e-01 | 0.640 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.329319e-01 | 0.633 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.329319e-01 | 0.633 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.329319e-01 | 0.633 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.330320e-01 | 0.633 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.387463e-01 | 0.622 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.387463e-01 | 0.622 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.387463e-01 | 0.622 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.404984e-01 | 0.619 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.416488e-01 | 0.617 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.451697e-01 | 0.611 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.487090e-01 | 0.604 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.487090e-01 | 0.604 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.493314e-01 | 0.603 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.511181e-01 | 0.600 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.511181e-01 | 0.600 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.522464e-01 | 0.598 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 2.522464e-01 | 0.598 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.526081e-01 | 0.598 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.529915e-01 | 0.597 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.529915e-01 | 0.597 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.529915e-01 | 0.597 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.538389e-01 | 0.595 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.622856e-01 | 0.581 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.622856e-01 | 0.581 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.622856e-01 | 0.581 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.622856e-01 | 0.581 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.622856e-01 | 0.581 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.622856e-01 | 0.581 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.624863e-01 | 0.581 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.631065e-01 | 0.580 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.633727e-01 | 0.579 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.633727e-01 | 0.579 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.633727e-01 | 0.579 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.633727e-01 | 0.579 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.633727e-01 | 0.579 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.633727e-01 | 0.579 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.633727e-01 | 0.579 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.670486e-01 | 0.573 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.686944e-01 | 0.571 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.689318e-01 | 0.570 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.771360e-01 | 0.557 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.771360e-01 | 0.557 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.818778e-01 | 0.550 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.829271e-01 | 0.548 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.829271e-01 | 0.548 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.829271e-01 | 0.548 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.829271e-01 | 0.548 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.829271e-01 | 0.548 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.829271e-01 | 0.548 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.829271e-01 | 0.548 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.829271e-01 | 0.548 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.829271e-01 | 0.548 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.829271e-01 | 0.548 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.830490e-01 | 0.548 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.834037e-01 | 0.548 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.848571e-01 | 0.545 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.857114e-01 | 0.544 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.857114e-01 | 0.544 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.857114e-01 | 0.544 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.859022e-01 | 0.544 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 2.879675e-01 | 0.541 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.920619e-01 | 0.535 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.920619e-01 | 0.535 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.920619e-01 | 0.535 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.920619e-01 | 0.535 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.920619e-01 | 0.535 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.016275e-01 | 0.521 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.016275e-01 | 0.521 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.016275e-01 | 0.521 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.016275e-01 | 0.521 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.016275e-01 | 0.521 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.031163e-01 | 0.518 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.040902e-01 | 0.517 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.040902e-01 | 0.517 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.040902e-01 | 0.517 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.040902e-01 | 0.517 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.040902e-01 | 0.517 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.040902e-01 | 0.517 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.040902e-01 | 0.517 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.040902e-01 | 0.517 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 3.040902e-01 | 0.517 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.040902e-01 | 0.517 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.040902e-01 | 0.517 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.046215e-01 | 0.516 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.046215e-01 | 0.516 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.046422e-01 | 0.516 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.046422e-01 | 0.516 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.046422e-01 | 0.516 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.120652e-01 | 0.506 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.177787e-01 | 0.498 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.177787e-01 | 0.498 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.205330e-01 | 0.494 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.220454e-01 | 0.492 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.220454e-01 | 0.492 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.237863e-01 | 0.490 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.260624e-01 | 0.487 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.260624e-01 | 0.487 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.260624e-01 | 0.487 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.260624e-01 | 0.487 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 3.263467e-01 | 0.486 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.263467e-01 | 0.486 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.263467e-01 | 0.486 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.370700e-01 | 0.472 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.386149e-01 | 0.470 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.388781e-01 | 0.470 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.430898e-01 | 0.465 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.430898e-01 | 0.465 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.430898e-01 | 0.465 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.430898e-01 | 0.465 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.443776e-01 | 0.463 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.443776e-01 | 0.463 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.443776e-01 | 0.463 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.443776e-01 | 0.463 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.443776e-01 | 0.463 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.443776e-01 | 0.463 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.443776e-01 | 0.463 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.443776e-01 | 0.463 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.443776e-01 | 0.463 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.443776e-01 | 0.463 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.476515e-01 | 0.459 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.493323e-01 | 0.457 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.493323e-01 | 0.457 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.511806e-01 | 0.454 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.511806e-01 | 0.454 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.511806e-01 | 0.454 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.511806e-01 | 0.454 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.514786e-01 | 0.454 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.520403e-01 | 0.453 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.520403e-01 | 0.453 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.520403e-01 | 0.453 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.558116e-01 | 0.449 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.581821e-01 | 0.446 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.581821e-01 | 0.446 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.581821e-01 | 0.446 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.581821e-01 | 0.446 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.581821e-01 | 0.446 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.581821e-01 | 0.446 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.581821e-01 | 0.446 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.693168e-01 | 0.433 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.693168e-01 | 0.433 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.693168e-01 | 0.433 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.735937e-01 | 0.428 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.735937e-01 | 0.428 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.738393e-01 | 0.427 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.760233e-01 | 0.425 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.760233e-01 | 0.425 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.760233e-01 | 0.425 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.818713e-01 | 0.418 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.818713e-01 | 0.418 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.818713e-01 | 0.418 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.819660e-01 | 0.418 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.838770e-01 | 0.416 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.838770e-01 | 0.416 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.838770e-01 | 0.416 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.838770e-01 | 0.416 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.838770e-01 | 0.416 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.838770e-01 | 0.416 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.838770e-01 | 0.416 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.838770e-01 | 0.416 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.838770e-01 | 0.416 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.838770e-01 | 0.416 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.909895e-01 | 0.408 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.914190e-01 | 0.407 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.914190e-01 | 0.407 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.991324e-01 | 0.399 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.007760e-01 | 0.397 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.007760e-01 | 0.397 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.007760e-01 | 0.397 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.014385e-01 | 0.396 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.014385e-01 | 0.396 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.113433e-01 | 0.386 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.113833e-01 | 0.386 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.113833e-01 | 0.386 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.126043e-01 | 0.384 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.126043e-01 | 0.384 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.157566e-01 | 0.381 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.208703e-01 | 0.376 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.209446e-01 | 0.376 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.223104e-01 | 0.374 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.223104e-01 | 0.374 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.223104e-01 | 0.374 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.223104e-01 | 0.374 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.223104e-01 | 0.374 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.223104e-01 | 0.374 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.223104e-01 | 0.374 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.223104e-01 | 0.374 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.253480e-01 | 0.371 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.253480e-01 | 0.371 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.255433e-01 | 0.371 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.255433e-01 | 0.371 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.255433e-01 | 0.371 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.255433e-01 | 0.371 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.255433e-01 | 0.371 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.255433e-01 | 0.371 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.255433e-01 | 0.371 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 4.255433e-01 | 0.371 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.270514e-01 | 0.370 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.335044e-01 | 0.363 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.341001e-01 | 0.362 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.341001e-01 | 0.362 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.358007e-01 | 0.361 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.404405e-01 | 0.356 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.404405e-01 | 0.356 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.404405e-01 | 0.356 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.404405e-01 | 0.356 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.447876e-01 | 0.352 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.483619e-01 | 0.348 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.496564e-01 | 0.347 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.496564e-01 | 0.347 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.496564e-01 | 0.347 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.496564e-01 | 0.347 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.496564e-01 | 0.347 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.512501e-01 | 0.346 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.554197e-01 | 0.342 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.594353e-01 | 0.338 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.594353e-01 | 0.338 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.594353e-01 | 0.338 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.594353e-01 | 0.338 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.594664e-01 | 0.338 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.594664e-01 | 0.338 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.594664e-01 | 0.338 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.594664e-01 | 0.338 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.594664e-01 | 0.338 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.594664e-01 | 0.338 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.594664e-01 | 0.338 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.594664e-01 | 0.338 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.594664e-01 | 0.338 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.594664e-01 | 0.338 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.594664e-01 | 0.338 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.689262e-01 | 0.329 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.689262e-01 | 0.329 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.689262e-01 | 0.329 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.689262e-01 | 0.329 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.689262e-01 | 0.329 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.689262e-01 | 0.329 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.689262e-01 | 0.329 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.689262e-01 | 0.329 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.736264e-01 | 0.325 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.736264e-01 | 0.325 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.736264e-01 | 0.325 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.736264e-01 | 0.325 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.736264e-01 | 0.325 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.736264e-01 | 0.325 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.765102e-01 | 0.322 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.765102e-01 | 0.322 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.857885e-01 | 0.314 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.858383e-01 | 0.314 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 4.858383e-01 | 0.314 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 4.858383e-01 | 0.314 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.858383e-01 | 0.314 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.858383e-01 | 0.314 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 4.858383e-01 | 0.314 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.858383e-01 | 0.314 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.858383e-01 | 0.314 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.858383e-01 | 0.314 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.858383e-01 | 0.314 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.858383e-01 | 0.314 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.858383e-01 | 0.314 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.858383e-01 | 0.314 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.858383e-01 | 0.314 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.861145e-01 | 0.313 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.951900e-01 | 0.305 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.951900e-01 | 0.305 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.951900e-01 | 0.305 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.951900e-01 | 0.305 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.951900e-01 | 0.305 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.951900e-01 | 0.305 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.951900e-01 | 0.305 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.951900e-01 | 0.305 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.951900e-01 | 0.305 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.965160e-01 | 0.304 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.967411e-01 | 0.304 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.967411e-01 | 0.304 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 4.967411e-01 | 0.304 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.967411e-01 | 0.304 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.967411e-01 | 0.304 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.967411e-01 | 0.304 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.969227e-01 | 0.304 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.970233e-01 | 0.304 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.971911e-01 | 0.303 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.971911e-01 | 0.303 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.971911e-01 | 0.303 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.971911e-01 | 0.303 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.971911e-01 | 0.303 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.972098e-01 | 0.303 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.972098e-01 | 0.303 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.973321e-01 | 0.303 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.132219e-01 | 0.290 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.178146e-01 | 0.286 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.178146e-01 | 0.286 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.178146e-01 | 0.286 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.202915e-01 | 0.284 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.202915e-01 | 0.284 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.202915e-01 | 0.284 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.202915e-01 | 0.284 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.238025e-01 | 0.281 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.238025e-01 | 0.281 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.238025e-01 | 0.281 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.252116e-01 | 0.280 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.271097e-01 | 0.278 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.293726e-01 | 0.276 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.293726e-01 | 0.276 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.293726e-01 | 0.276 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.293726e-01 | 0.276 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.293726e-01 | 0.276 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.293726e-01 | 0.276 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.329861e-01 | 0.273 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.342744e-01 | 0.272 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.398078e-01 | 0.268 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.398078e-01 | 0.268 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.398078e-01 | 0.268 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.398078e-01 | 0.268 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.398078e-01 | 0.268 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.398078e-01 | 0.268 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.398078e-01 | 0.268 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.398078e-01 | 0.268 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.398078e-01 | 0.268 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.398078e-01 | 0.268 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.398078e-01 | 0.268 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.398078e-01 | 0.268 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.398078e-01 | 0.268 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.428761e-01 | 0.265 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.482261e-01 | 0.261 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.500430e-01 | 0.260 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.500430e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.500430e-01 | 0.260 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.533196e-01 | 0.257 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.619441e-01 | 0.250 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.619441e-01 | 0.250 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.645679e-01 | 0.248 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.649007e-01 | 0.248 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.649007e-01 | 0.248 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.649007e-01 | 0.248 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.712220e-01 | 0.243 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.712220e-01 | 0.243 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.712220e-01 | 0.243 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.754091e-01 | 0.240 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 5.754091e-01 | 0.240 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.873796e-01 | 0.231 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.881152e-01 | 0.231 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.881152e-01 | 0.231 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.881152e-01 | 0.231 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.881152e-01 | 0.231 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.881152e-01 | 0.231 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.881152e-01 | 0.231 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.881152e-01 | 0.231 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.881152e-01 | 0.231 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.881152e-01 | 0.231 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.881152e-01 | 0.231 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.881152e-01 | 0.231 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.881152e-01 | 0.231 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.881152e-01 | 0.231 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.881152e-01 | 0.231 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.881152e-01 | 0.231 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.902505e-01 | 0.229 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.928662e-01 | 0.227 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.928662e-01 | 0.227 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 5.928662e-01 | 0.227 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 5.928662e-01 | 0.227 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 5.928662e-01 | 0.227 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.928662e-01 | 0.227 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.928662e-01 | 0.227 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.928662e-01 | 0.227 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.958303e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.958303e-01 | 0.225 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.966230e-01 | 0.224 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.990004e-01 | 0.223 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.998599e-01 | 0.222 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.998599e-01 | 0.222 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.998599e-01 | 0.222 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.998599e-01 | 0.222 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 5.998599e-01 | 0.222 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.998599e-01 | 0.222 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.069982e-01 | 0.217 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.071268e-01 | 0.217 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.141999e-01 | 0.212 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.181596e-01 | 0.209 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.181596e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.209701e-01 | 0.207 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.221261e-01 | 0.206 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.233660e-01 | 0.205 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.313542e-01 | 0.200 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.313542e-01 | 0.200 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.313542e-01 | 0.200 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.313542e-01 | 0.200 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.313542e-01 | 0.200 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.313542e-01 | 0.200 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.313542e-01 | 0.200 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.313542e-01 | 0.200 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.313542e-01 | 0.200 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.313542e-01 | 0.200 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.313542e-01 | 0.200 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.313542e-01 | 0.200 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.335813e-01 | 0.198 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.401050e-01 | 0.194 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.459081e-01 | 0.190 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.467465e-01 | 0.189 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.494268e-01 | 0.187 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.497321e-01 | 0.187 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.497321e-01 | 0.187 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.497321e-01 | 0.187 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.497321e-01 | 0.187 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.497321e-01 | 0.187 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.499579e-01 | 0.187 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.568646e-01 | 0.183 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.603149e-01 | 0.180 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.674760e-01 | 0.176 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.674760e-01 | 0.176 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.674760e-01 | 0.176 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.674760e-01 | 0.176 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.674760e-01 | 0.176 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.674760e-01 | 0.176 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.700564e-01 | 0.174 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.700564e-01 | 0.174 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.700564e-01 | 0.174 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.700564e-01 | 0.174 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.700564e-01 | 0.174 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 6.700564e-01 | 0.174 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.700564e-01 | 0.174 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.700564e-01 | 0.174 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.700564e-01 | 0.174 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.700564e-01 | 0.174 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.700564e-01 | 0.174 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.700564e-01 | 0.174 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.700564e-01 | 0.174 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.700564e-01 | 0.174 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.747071e-01 | 0.171 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.757089e-01 | 0.170 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.757089e-01 | 0.170 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.757089e-01 | 0.170 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.757089e-01 | 0.170 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 6.757089e-01 | 0.170 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.757089e-01 | 0.170 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.757089e-01 | 0.170 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.757089e-01 | 0.170 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.757089e-01 | 0.170 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.757089e-01 | 0.170 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.836269e-01 | 0.165 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.836269e-01 | 0.165 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.871052e-01 | 0.163 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.880672e-01 | 0.162 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.880672e-01 | 0.162 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.880672e-01 | 0.162 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.909716e-01 | 0.161 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.925650e-01 | 0.160 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.000943e-01 | 0.155 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.000943e-01 | 0.155 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.010197e-01 | 0.154 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.010197e-01 | 0.154 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.046974e-01 | 0.152 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.046974e-01 | 0.152 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.046974e-01 | 0.152 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.046974e-01 | 0.152 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.046974e-01 | 0.152 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.046974e-01 | 0.152 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.046974e-01 | 0.152 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.046974e-01 | 0.152 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.046974e-01 | 0.152 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.046974e-01 | 0.152 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.046974e-01 | 0.152 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.046974e-01 | 0.152 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.046974e-01 | 0.152 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 7.046974e-01 | 0.152 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.046974e-01 | 0.152 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.046974e-01 | 0.152 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.076862e-01 | 0.150 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.076862e-01 | 0.150 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.134924e-01 | 0.147 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.134924e-01 | 0.147 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.147744e-01 | 0.146 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.188731e-01 | 0.143 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.229360e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.229360e-01 | 0.141 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.229360e-01 | 0.141 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.229360e-01 | 0.141 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.229360e-01 | 0.141 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.229360e-01 | 0.141 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.229360e-01 | 0.141 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.238593e-01 | 0.140 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.252615e-01 | 0.140 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.263434e-01 | 0.139 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.263434e-01 | 0.139 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.263434e-01 | 0.139 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.337062e-01 | 0.134 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.337062e-01 | 0.134 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.337062e-01 | 0.134 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.354425e-01 | 0.133 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.357033e-01 | 0.133 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.357033e-01 | 0.133 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.357033e-01 | 0.133 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.357033e-01 | 0.133 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.357033e-01 | 0.133 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.357033e-01 | 0.133 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.357033e-01 | 0.133 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.357033e-01 | 0.133 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.357033e-01 | 0.133 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.357033e-01 | 0.133 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.357033e-01 | 0.133 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.357033e-01 | 0.133 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.357033e-01 | 0.133 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.357033e-01 | 0.133 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.440542e-01 | 0.128 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.440542e-01 | 0.128 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.442894e-01 | 0.128 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.442894e-01 | 0.128 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.461004e-01 | 0.127 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.486229e-01 | 0.126 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.490084e-01 | 0.126 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.490084e-01 | 0.126 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.510350e-01 | 0.124 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.608382e-01 | 0.119 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.634552e-01 | 0.117 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.634552e-01 | 0.117 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.634552e-01 | 0.117 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.634552e-01 | 0.117 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.634552e-01 | 0.117 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.634552e-01 | 0.117 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.634552e-01 | 0.117 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.634552e-01 | 0.117 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.634552e-01 | 0.117 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.642150e-01 | 0.117 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.642150e-01 | 0.117 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.642150e-01 | 0.117 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.642150e-01 | 0.117 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.743217e-01 | 0.111 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.767187e-01 | 0.110 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.775737e-01 | 0.109 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.816004e-01 | 0.107 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.827773e-01 | 0.106 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.827773e-01 | 0.106 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.827773e-01 | 0.106 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 7.827773e-01 | 0.106 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.836621e-01 | 0.106 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.882946e-01 | 0.103 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.882946e-01 | 0.103 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.882946e-01 | 0.103 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.882946e-01 | 0.103 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.882946e-01 | 0.103 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.882946e-01 | 0.103 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.882946e-01 | 0.103 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.882946e-01 | 0.103 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.882946e-01 | 0.103 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.882946e-01 | 0.103 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.883034e-01 | 0.103 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.917215e-01 | 0.101 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.917215e-01 | 0.101 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.949599e-01 | 0.100 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.977286e-01 | 0.098 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.035038e-01 | 0.095 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.035038e-01 | 0.095 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.078445e-01 | 0.093 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.105270e-01 | 0.091 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.105270e-01 | 0.091 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.105270e-01 | 0.091 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.105270e-01 | 0.091 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.105270e-01 | 0.091 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.105270e-01 | 0.091 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.105270e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.115771e-01 | 0.091 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.160789e-01 | 0.088 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.160789e-01 | 0.088 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.160789e-01 | 0.088 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.263202e-01 | 0.083 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.269238e-01 | 0.083 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.287554e-01 | 0.082 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.304257e-01 | 0.081 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.304257e-01 | 0.081 | 0 | 0 |
| Acetylation | R-HSA-156582 | 8.304257e-01 | 0.081 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.304257e-01 | 0.081 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.304257e-01 | 0.081 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.304257e-01 | 0.081 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.304257e-01 | 0.081 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.304257e-01 | 0.081 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.304257e-01 | 0.081 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.304257e-01 | 0.081 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.304257e-01 | 0.081 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.304257e-01 | 0.081 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.304257e-01 | 0.081 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.304257e-01 | 0.081 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.309536e-01 | 0.080 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.309536e-01 | 0.080 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.317549e-01 | 0.080 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.317549e-01 | 0.080 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.364657e-01 | 0.078 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.447339e-01 | 0.073 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.447339e-01 | 0.073 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.447339e-01 | 0.073 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.454571e-01 | 0.073 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.479786e-01 | 0.072 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.482357e-01 | 0.071 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.482357e-01 | 0.071 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.482357e-01 | 0.071 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.482357e-01 | 0.071 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.482357e-01 | 0.071 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.512820e-01 | 0.070 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.546112e-01 | 0.068 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.565159e-01 | 0.067 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.574854e-01 | 0.067 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.574854e-01 | 0.067 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.574854e-01 | 0.067 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.618621e-01 | 0.065 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.630530e-01 | 0.064 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.630530e-01 | 0.064 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.641761e-01 | 0.063 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.641761e-01 | 0.063 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.641761e-01 | 0.063 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.641761e-01 | 0.063 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.641761e-01 | 0.063 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.641761e-01 | 0.063 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.641761e-01 | 0.063 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.641761e-01 | 0.063 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.641761e-01 | 0.063 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.641761e-01 | 0.063 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.657876e-01 | 0.063 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.668256e-01 | 0.062 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.692722e-01 | 0.061 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.712006e-01 | 0.060 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.712006e-01 | 0.060 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.712006e-01 | 0.060 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.747051e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.747051e-01 | 0.058 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.784431e-01 | 0.056 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.784431e-01 | 0.056 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.784431e-01 | 0.056 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.784431e-01 | 0.056 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.784431e-01 | 0.056 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.784431e-01 | 0.056 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.784431e-01 | 0.056 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.784431e-01 | 0.056 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.789339e-01 | 0.056 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.801563e-01 | 0.055 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.836279e-01 | 0.054 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.836290e-01 | 0.054 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.862678e-01 | 0.052 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.901971e-01 | 0.051 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.912122e-01 | 0.050 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.912122e-01 | 0.050 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.912122e-01 | 0.050 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.912122e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.912122e-01 | 0.050 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.912122e-01 | 0.050 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.913163e-01 | 0.050 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.922968e-01 | 0.049 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.922968e-01 | 0.049 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.967930e-01 | 0.047 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.997965e-01 | 0.046 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.997965e-01 | 0.046 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.006047e-01 | 0.045 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.010259e-01 | 0.045 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.010259e-01 | 0.045 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.026406e-01 | 0.044 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.026406e-01 | 0.044 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.026406e-01 | 0.044 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.026406e-01 | 0.044 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.026406e-01 | 0.044 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.026406e-01 | 0.044 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.026406e-01 | 0.044 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.051816e-01 | 0.043 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.053648e-01 | 0.043 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.060209e-01 | 0.043 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.076394e-01 | 0.042 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.076394e-01 | 0.042 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.076394e-01 | 0.042 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.076394e-01 | 0.042 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.079745e-01 | 0.042 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.128691e-01 | 0.040 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.128691e-01 | 0.040 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.128691e-01 | 0.040 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.128691e-01 | 0.040 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.158170e-01 | 0.038 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.158170e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.174628e-01 | 0.037 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.177796e-01 | 0.037 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.220235e-01 | 0.035 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.220235e-01 | 0.035 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.220235e-01 | 0.035 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.220235e-01 | 0.035 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.220235e-01 | 0.035 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.220235e-01 | 0.035 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.239947e-01 | 0.034 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.255843e-01 | 0.034 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.269585e-01 | 0.033 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.296536e-01 | 0.032 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.296536e-01 | 0.032 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.296536e-01 | 0.032 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.302165e-01 | 0.031 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.302165e-01 | 0.031 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.302165e-01 | 0.031 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.302165e-01 | 0.031 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.337373e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.357373e-01 | 0.029 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.357373e-01 | 0.029 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.357373e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.375492e-01 | 0.028 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.375492e-01 | 0.028 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.383219e-01 | 0.028 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.412179e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.426694e-01 | 0.026 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.441117e-01 | 0.025 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.441117e-01 | 0.025 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.441117e-01 | 0.025 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.441117e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.441117e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.441117e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.464388e-01 | 0.024 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.499850e-01 | 0.022 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.499850e-01 | 0.022 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.499850e-01 | 0.022 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.510944e-01 | 0.022 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.511305e-01 | 0.022 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.511305e-01 | 0.022 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.552414e-01 | 0.020 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.552414e-01 | 0.020 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.554280e-01 | 0.020 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.554280e-01 | 0.020 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.554280e-01 | 0.020 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.599456e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.599456e-01 | 0.018 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.599456e-01 | 0.018 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.599456e-01 | 0.018 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.599456e-01 | 0.018 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.623114e-01 | 0.017 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.624361e-01 | 0.017 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.629624e-01 | 0.016 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.635990e-01 | 0.016 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.641556e-01 | 0.016 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.641556e-01 | 0.016 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.641556e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.641556e-01 | 0.016 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.641556e-01 | 0.016 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.641556e-01 | 0.016 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.648030e-01 | 0.016 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.679234e-01 | 0.014 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.685596e-01 | 0.014 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.712036e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.712036e-01 | 0.013 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.712953e-01 | 0.013 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.712953e-01 | 0.013 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.712953e-01 | 0.013 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.712953e-01 | 0.013 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.712953e-01 | 0.013 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.743129e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.743129e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.743129e-01 | 0.011 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.745266e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.748289e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.750692e-01 | 0.011 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.768198e-01 | 0.010 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.769416e-01 | 0.010 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.770135e-01 | 0.010 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.781264e-01 | 0.010 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.789126e-01 | 0.009 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.789126e-01 | 0.009 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.794303e-01 | 0.009 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.808217e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.815931e-01 | 0.008 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.815931e-01 | 0.008 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.835286e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.848502e-01 | 0.007 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.849364e-01 | 0.007 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.852607e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.855957e-01 | 0.006 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.856666e-01 | 0.006 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.856714e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.868107e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.878114e-01 | 0.005 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.878785e-01 | 0.005 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.881978e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.881978e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.883964e-01 | 0.005 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.893693e-01 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.894391e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.894391e-01 | 0.005 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.894391e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.894391e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.894391e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.896359e-01 | 0.005 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.905500e-01 | 0.004 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.905500e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.905500e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.905500e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.915440e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.923771e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.924335e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.924335e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.932295e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.935094e-01 | 0.003 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.937167e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.938449e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.945792e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.945792e-01 | 0.002 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.945792e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.950446e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.951496e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.955965e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.955965e-01 | 0.002 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.957437e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.959288e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.959288e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.962189e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.968911e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.969722e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.969722e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.970401e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.972183e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.977731e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.977890e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980744e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.982172e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.983162e-01 | 0.001 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.984049e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.984049e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.984908e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.984908e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.985729e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.986374e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.987103e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.987647e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.988879e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.989779e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.990855e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.990926e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.991819e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.992528e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.992528e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.993279e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.994141e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.994286e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.994434e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.994482e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.994758e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.994758e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995684e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.996045e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.996247e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.996247e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.996999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.997029e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997596e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997849e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998279e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998279e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998460e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998460e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998759e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998898e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998898e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999014e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999017e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999122e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999310e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999369e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999369e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999369e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999495e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999517e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999563e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999680e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999840e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999881e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999893e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999911e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999920e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999946e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999947e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999969e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999975e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999986e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999988e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999993e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999994e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
